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Introduction {#embj2018100087-sec-0001}
============

Ensuring species\' survival in perilous environments is a primary evolutionary demand. Therefore, central stress pathways, efficiently linking the brain and periphery, have evolved to form the hypothalamus--pituitary--adrenal axis (HPA) (Selye & Fortier, [1949](#embj2018100087-bib-0082){ref-type="ref"}; Bale & Vale, [2004](#embj2018100087-bib-0011){ref-type="ref"}; McEwen, [2008](#embj2018100087-bib-0052){ref-type="ref"}). By principle, corticotropin‐releasing hormone (CRH)‐containing(^+^) neurons of the paraventricular hypothalamic nucleus (PVN) gate output from the central nervous system (Swanson & Sawchenko, [1980](#embj2018100087-bib-0089){ref-type="ref"}) with CRH (Swanson *et al*, [1983](#embj2018100087-bib-0090){ref-type="ref"}, [1986](#embj2018100087-bib-0091){ref-type="ref"}), through pituitary amplification steps, triggering corticosteroid release from the adrenal glands for immediate metabolic mobilization (Rivier & Vale, [1983](#embj2018100087-bib-0071){ref-type="ref"}; Kovacs & Sawchenko, [1996](#embj2018100087-bib-0046){ref-type="ref"}). Nevertheless, stress, whether due to, e.g., predation or competition for reproduction, is unlikely a singular event. Therefore, secondary response pathways to enable an individual\'s prolonged vigilance might have evolved to confer added evolutionary benefit when responding to recurrent challenges. Seminal studies (Schulkin *et al*, [1994](#embj2018100087-bib-0080){ref-type="ref"}; McEwen & Sapolsky, [1995](#embj2018100087-bib-0049){ref-type="ref"}; Popoli *et al*, [2011](#embj2018100087-bib-0068){ref-type="ref"}) support this notion by documenting that corticosteroids released from the adrenals do not only produce feedback inhibition of hypothalamic and pituitary hormone secretion (Akana *et al*, [1992](#embj2018100087-bib-0001){ref-type="ref"}) but directly regulate limbic and reward circuits (Sapolsky, [2003](#embj2018100087-bib-0079){ref-type="ref"}) to gate coping and flexibility (e.g., "flight or fight" behaviors; Eriksen *et al*, [1999](#embj2018100087-bib-0024){ref-type="ref"}; McEwen *et al*, [2012](#embj2018100087-bib-0053){ref-type="ref"}), motivation (McEwen, [2005](#embj2018100087-bib-0050){ref-type="ref"}), memory (Roozendaal *et al*, [2009](#embj2018100087-bib-0075){ref-type="ref"}), and fear extinction (Korte, [2001](#embj2018100087-bib-0045){ref-type="ref"}; McEwen, [2005](#embj2018100087-bib-0050){ref-type="ref"}). The prefrontal cortex (PFC) has emerged as a central site to orchestrate coordinated responses to acute stress (McEwen, [2007](#embj2018100087-bib-0051){ref-type="ref"}) with glucocorticoid and mineralocorticoid receptors modulating its ability to integrate upstream emotional, sensory, cognitive, and spatial inputs (Patel *et al*, [2008](#embj2018100087-bib-0067){ref-type="ref"}; Gadek‐Michalska *et al*, [2013](#embj2018100087-bib-0033){ref-type="ref"}; Caudal *et al*, [2014](#embj2018100087-bib-0017){ref-type="ref"}).

In general terms, corticosteroids can change neuronal excitability through the cell‐type‐specific engagement of mineralocorticoid and glucocorticoid receptors with the former increasing and the latter suppressing neuronal activity (Joels & de Kloet, [1992](#embj2018100087-bib-0040){ref-type="ref"}). However, stress‐induced alertness (defined as heightened cortical network excitability for prolonged periods) might benefit from a single neural trigger, such as CRH^+^ neuroendocrine cells, for the tight temporal coupling and scaling of cortical excitability for conscious execution of stereotyped behaviors associated with vigilance and HPA‐induced peripheral energy mobilization. A neural link between CRH^+^ parvocellular cells and norepinephrinergic (NE) neurons of the locus coeruleus (LC) is of particular appeal because NE activity increases with the severity and duration of stress (Aston‐Jones *et al*, [1996](#embj2018100087-bib-0010){ref-type="ref"}; Chowdhury *et al*, [2000](#embj2018100087-bib-0018){ref-type="ref"}) and NE afferents of the PFC are poised to facilitate adaptive behaviors (Uematsu *et al*, [2017](#embj2018100087-bib-0097){ref-type="ref"}). Recently, CRH^+^ innervation of NE neurons has been described (Zhang *et al*, [2017](#embj2018100087-bib-0101){ref-type="ref"}), including at the ultrastructural level (Van Bockstaele *et al*, [1996](#embj2018100087-bib-0519){ref-type="ref"}). However, a monosynaptic circuit operating through excitatory CRH \[i.e., CRH acting at G~s~ protein‐coupled *Crhr1* and/or *Crhr2* receptors (De Souza, [1995](#embj2018100087-bib-0021){ref-type="ref"})\] seems insufficient to functionally convert short‐lived surges of excitability into long‐lasting NE sensitization for cortical stress adaptation, particularly since neuropeptide release likely commences only upon intense burst firing (Overton & Clark, [1997](#embj2018100087-bib-0065){ref-type="ref"}).

Here, we unmask an efficient mechanism coordinated by glutamate release from CRH neurons onto ependymal cells that line the wall of the 3^rd^ ventricle to trigger long‐range volume transmission by ciliary neurotrophic factor (CNTF) in the brain aqueductal system. Once reaching the LC, CNTF heightens NE output (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}A), as opposed to fast synaptic coupling known to evoke anxiety acutely (Zhang *et al*, [2017](#embj2018100087-bib-0101){ref-type="ref"}). We show the maintenance of NE excitability through CNTF‐induced sequential recruitment of secretagogin (*Scgn*) and extracellular signal‐regulated kinase 1 (*Erk1*) to increase tyrosine hydroxylase (TH) activity by phosphorylation for cortical NE production. Despite extensive NE innervation of the entire cortical mantle (Fuxe *et al*, [1968](#embj2018100087-bib-0029){ref-type="ref"}; Moore & Bloom, [1979](#embj2018100087-bib-0058){ref-type="ref"}; Aston‐Jones, [1995](#embj2018100087-bib-0009){ref-type="ref"}), this mechanism centers on the PFC where it is poised to efficiently reset network excitability (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}A; McCormick *et al*, [1991](#embj2018100087-bib-0048){ref-type="ref"}). Thus, the combination of genetic manipulation of *Cntf* and *Scgn* with opto‐/chemogenetics and biochemistry not only uncovers previously undescribed molecular determinants gating stress‐induced behavioral phenotypes but also offers targets for stress resilience.

![Hypothalamic corticotropin‐releasing hormone (CRH)‐releasing neurons innervate ependymal cells lining the 3^rd^ ventricle\
Cartoon depicting a multimodal signaling axis including a direct pathway between the paraventricular hypothalamic nucleus (PVN) and ventricular ependyma (1), volume transmission to the locus coeruleus (LC; 2) with norepinephrinergic projections to the prefrontal cortex (PFC; 3).Microinjection of AAV‐DIO‐mCherry virus particles into the PVN of *Crh*‐Ires‐Cre mice reveals mCherry‐containing processes oriented toward the 3^rd^ ventricle (3V; *arrowheads*). Scale bar = 60 μm.Single‐cell RNA‐seq reveals infrequent expression of *Crhr1, Crhr2*, and *Crhbp*, as opposed to glutamate and GABA receptor subunits (in *red*), by ependymal cells. Ependymal cells were classified by *Enkur* and *Foxj1* expression (Romanov *et al*, [2017b](#embj2018100087-bib-0074){ref-type="ref"}), and also contained *Cntf* mRNAs. (C1) Reconstruction of GRIA1^+^ ependymal cells receiving VGLUT2^+^ synapses (*arrowheads*). Asterisks denote nuclei. Scale bar = 12 μm.(1) Electron micrograph showing gap junction coupling (*arrowheads*) between ependymal cells. Scale bar = 250 nm. (2) Dye transfer among ependymal cells. "1^st^" indicates the cell probed directly. Arrowheads indicate secondary labeling in adjacent cells. Scale bar = 15 μm. (3) Postsynaptic currents (*arrowheads*) recorded in ependymal cells in control and upon exposure to AMPA (10 μM).*Upper panel:* Tonic inward current produced by bath‐applied AMPA (10 μM). *Lower panel:* Quantitative data from ependymal cells from *n \> *3 mice. Data in box plots represent medians and 10^th^, 25^th^, 75^th^, and 90^th^ percentiles. \*\**P \< *0.01 vs. baseline and wash‐out (ANOVA).Activating DREADD (hM3Dq) was microinjected into the PVN of *Crh*‐Ires‐Cre mice 14--17 days prior to *ex vivo* recordings. (1) Reconstruction of mCherry‐labeled terminals (*arrowheads*) in apposition to nestin^+^ ependyma. Scale bar = 7 μm. (2) DREADD activation by CNO in CRH terminals innervating ependymal cells induces inward currents (*arrowheads*), which are sensitive to NBQX, an AMPA receptor antagonist (20 μM).](EMBJ-37-e100087-g002){#embj2018100087-fig-0001}

Results {#embj2018100087-sec-0002}
=======

Ependymal cells are an intrahypothalamic target of CRH neurons {#embj2018100087-sec-0003}
--------------------------------------------------------------

Paraventricular CRH neurons of the hypothalamus release CRH into the median eminence to control the HPA stress axis by facilitating adrenocorticotropic hormone (ACTH) release from the anterior pituitary (Bale & Vale, [2004](#embj2018100087-bib-0011){ref-type="ref"}). However, whether paraventricular CRH neurons project to other targets within the hypothalamus, as proposed for other types of parvocellular neurons (Ter Horst & Luiten, [1987](#embj2018100087-bib-0095){ref-type="ref"}; Dai *et al*, [1998](#embj2018100087-bib-0020){ref-type="ref"}), remains undefined. First, we addressed alternative synaptic sites for CRH neurons by microinjecting adeno‐associated virus (AAV8) particles encapsulating an mCherry reporter into adult *Crh‐Ires*‐Cre mice that are commonly used to test stress‐related behaviors (Fuzesi *et al*, [2016](#embj2018100087-bib-0032){ref-type="ref"}). By postoperative days 5--7, mCherry‐labeled processes emanating from CRH neurons that reside in the PVN coursed toward the 3^rd^ ventricle (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}B) with mCherry^+^ bouton‐like varicosities lining the outermost ependymal layer of the 3^rd^ ventricle. Next, we tested whether ependymal cells could directly respond to synaptic signals of CRH^+^ neurons by using single‐cell RNA‐seq to survey their CRH, glutamate, and GABA receptor contents (Romanov *et al*, [2017b](#embj2018100087-bib-0074){ref-type="ref"}). Ependymal cells, clustered by their expression of *Enkur* and *Foxj1* protogenes (Romanov *et al*, [2017b](#embj2018100087-bib-0074){ref-type="ref"}), predominantly expressed mRNA transcripts for glutamate and select GABA~A~ receptor subunits (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}C) with unexpectedly sparse mRNA content for *Crhr1* and *Crhr2* receptors. These data suggest that ependymal cells could respond to glutamate (co‐)released from "stress‐on" CRH^+^ neuroendocrine cells (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}, [2017b](#embj2018100087-bib-0074){ref-type="ref"}).

We have developed *Crh‐Ires‐*Cre::*egfp* mice to demonstrate that EGFP^+^ nerve endings contained vesicular glutamate transporter 2 (VGLUT2; Fig [EV1](#embj2018100087-fig-0001ev){ref-type="fig"}A and A1) and less so VGLUT1 (Fig [EV1](#embj2018100087-fig-0001ev){ref-type="fig"}A) along the 3^rd^ ventricle wall, suggesting the likelihood of glutamate release from CRH^+^ terminals. We then confirmed that VGLUT2^+^ nerve endings apposed ependymal cells that expressed GRIA1 (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}C1), the α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionate (AMPA) receptor subunit most abundantly expressed by ependymal cells at the mRNA level (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}C). Notably, our three‐dimensional tissue reconstructions revealed that only a subset of ependymal cells received VGLUT2^+^ innervation (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}C1), which could preclude their widespread and synchronous synaptic activation. However, ultrastructural analysis demonstrated that ependymal cells in the dorsolateral segment of the 3^rd^ ventricle wall are connected by gap junctions (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}D1) with their plasmalemma often convoluted (Fig [EV1](#embj2018100087-fig-0001ev){ref-type="fig"}B) to increase surface contact (Vanslembrouck *et al*, [2018](#embj2018100087-bib-0098){ref-type="ref"}). These data were substantiated by dye transfer from biocytin‐loaded ependymal cells to their closest neighbors (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}D2). Thus, gap junctions are the structural basis to convert the synaptic activation of "first‐responder" ependymal cells to synchronous cell‐state changes in a larger ependymal network.

![Glutamatergic inputs to ependymal cells lining the 3^rd^ ventricle (related to Fig [1](#embj2018100087-fig-0001){ref-type="fig"})\
EGFP^+^ nerve endings from *Crh‐Ires*‐Cre::*egfp* mice along the wall of the 3^rd^ ventricle (bottom edge of each image) contained either VGLUT2 (1) or VGLUT1 (2) immunoreactivities (*open arrowheads*). Orthogonal projections. (A1) Three‐dimensional rendering of VGLUT2^+^ nerve endings (*open arrowheads*) along nestin^+^ ependymal cells. Scale bars = 3 μm (1, 2) and 10 μm (A1).Electron micrographs showing gap junctions (*arrowheads*) between the convoluting plasmalemma of ependymal cells. Scale bars = 250 nm.Biophysical parameters of ependymal cell membranes, including resting membrane potential (C), and current‐clamp (C1) and voltage‐clamp (C2) profiles in response to 20 pA and 10 mV depolarization steps, respectively. I‐V relationship is shown in (C3). Data from *n *=* *10 cells are shown.AMPA superfusion significantly increases the frequency of spontaneous postsynaptic currents in ventricular ependyma. \*\**P \< *0.01 (paired Student\'s *t*‐test), *n *=* *10 cells/group. In the meantime, the amplitude (D1), rise time (D2), and decay time (D3) of such currents remained unchanged (for all parameters, *P \> *0.1).Data information: Data are expressed as means ± s.e.m.](EMBJ-37-e100087-g003){#embj2018100087-fig-0001ev}

We used patch‐clamp electrophysiology *ex vivo* to monitor whether ependymal cells receive synaptic inputs. Firstly, ependymal cells (for basic membrane properties, see Fig [EV1](#embj2018100087-fig-0001ev){ref-type="fig"}C--C3) produced spontaneous postsynaptic currents, which increased in frequency when bath‐applying AMPA (10 μM; Figs [1](#embj2018100087-fig-0001){ref-type="fig"}D3 and [EV1](#embj2018100087-fig-0001ev){ref-type="fig"}D--D3). Secondly, they invariably responded to AMPA superfusion by generating long‐lasting inward currents when held at −70 mV (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}E). We then addressed whether glutamatergic innervation of ependymal cells originates from CRH neurons by microinjecting adeno‐associated virus (AAV) particles carrying Cre‐dependent activating DREADD (hM3Dq) in tandem with an mCherry reporter (Alexander *et al*, [2009](#embj2018100087-bib-0002){ref-type="ref"}) into the PVN (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}F). Histochemical localization of mCherry recapitulated the distribution of VGLUT2^+^ synaptic puncta along ventricular ependyma (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}F1), supporting the existence of a direct projection from parvocellular CRH neurons. Thereafter, we applied the DREADD agonist clozapine N‐oxide (CNO, 10 μM) to acute brain slices to show the emergence of inward currents in ependymal cells, which were completely abolished by superfusion of 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo\[f\]chinoxalin‐2,3‐dion (NBQX, 20 μM), an AMPA receptor antagonist (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}F2). Overall, these data suggest that ependymal cells along the anterior‐dorsal segment of the 3^rd^ ventricle are intrahypothalamic targets for CRH neurons and are tonically excited by glutamate.

Glutamatergic neurotransmission facilitates CNTF release into the cerebrospinal fluid upon acute stress {#embj2018100087-sec-0004}
-------------------------------------------------------------------------------------------------------

The existence of a monosynaptic pathway originating from CRH^+^ neurons and innervating ventricular ependyma points to the stress‐induced release of bioactive substances into the cerebrospinal fluid. *Crh‐Ires‐*Cre::*egfp* mice were informative to reveal the genuine extent of EGFP^+^ innervation within the proximity (\< 15 μm) of the wall of the 3^rd^ ventricle through lifetime synapse labeling (Fig [2](#embj2018100087-fig-0002){ref-type="fig"}A). In turn, quantitative histochemistry for CRH showed that acute formalin stress significantly increases the density of CRH^+^ boutons targeting the wall of the 3^rd^ ventricle (in rats: 6.93 ± 0.67 in control vs. 13.41 ± 0.93 20 min after stress, *P *\<* *0.05; Fig [2](#embj2018100087-fig-0002){ref-type="fig"}A1; [Appendix Fig S1A](#embj2018100087-sup-0001){ref-type="supplementary-material"}). Subsequently, we used *cfos*‐Cre^ERT2^::*ROSA26‐stop‐ZsGreen1* ^*f*/*f*^ mice in an activity "TRAP" approach (Guenthner *et al*, [2013](#embj2018100087-bib-0034){ref-type="ref"}; Fig [2](#embj2018100087-fig-0002){ref-type="fig"}B), as well as histochemical detection of c‐Fos itself (Fig [2](#embj2018100087-fig-0002){ref-type="fig"}C; [Appendix Fig S1B](#embj2018100087-sup-0001){ref-type="supplementary-material"}) to show that formalin stress significantly increases the density of both *ZsGreen1* ^+^ (at 48 h; Fig [2](#embj2018100087-fig-0002){ref-type="fig"}B1) and c‐Fos^+^ (at 2 h; Fig [2](#embj2018100087-fig-0002){ref-type="fig"}C) ependymal cells that co‐express glial fibrillary acidic protein^+^ (Fig [2](#embj2018100087-fig-0002){ref-type="fig"}B1). The localization of stress‐activated ependymal cells to the cranial domain of the 3^rd^ ventricle (*P *\<* *0.05; [Appendix Fig S1C](#embj2018100087-sup-0001){ref-type="supplementary-material"}) resembles that of "light cells", which carry stereocilia and supposedly secrete bioactive substrates into the ventricular space (Mitro, [1981](#embj2018100087-bib-0056){ref-type="ref"}).

![Acute stress induces ciliary neurotrophic factor release from ependymal cells into the cerebrospinal fluid\
CRH terminals around ependymal cells (asterisks) of the 3^rd^ ventricle marked by lifetime GFP labeling in *Crh‐Ires‐*Cre*::egfp* mice (*n \> *3 mice/group). Scale bar = 10 μm. (A~1~) The density of CRH^+^ boutons is increased upon acute stress. \**P \< *0.05.Experimental design of activity "TRAP" experiments using coincidence detection in *cfos*‐Cre^ERT2^ mice. (B1) *Left:* Representative images of *ZsGreen1* ^+^ ependymal cells in the dorsolateral domain of the 3^rd^ ventricle wall, closest to the PVN, after acute stress (*arrowheads*). Inset identifies GFAP^+^/glutamine synthetase (GS)^+^ ependyma. Scale bar = 150 μm. *Right*: Quantitative analysis collected within a 15‐μm‐broad band around the 3^rd^ ventricle. \**P \< *0.05, *n *=* *7 mice/group.Quantitative histochemistry for c‐Fos 2 h after formalin stress. *Left: Open arrowheads* point to the increased density of c‐Fos^+^ ependymal lining the 3^rd^ ventricle. *n *=* *4 mice/group. Scale bar = 150 μm. *Right*: Quantitative data on ependymal cells directly exposed at the ventricular surface. \*\**P \< *0.01.Ependymal cells express CNTF in wild‐type mice (*solid arrowheads*). *Cntf* ^−/−^ mice were used to validate our histochemical results with their ependyma devoid of CNTF‐like immunoreactivity (*open arrowheads*). (D1) CNTF^+^ ependyma co‐express GFAP. Hoechst 33,342 was used as nuclear counterstain. (D2) EGFP^+^ nerve endings of EGFP‐expressing CRH neurons appose ependymal cells (EC; *arrowheads*) lining the 3^rd^ ventricle. Orthogonal projection. Scale bars = 120 μm (D), 5 μm (D1), and 8 μm (D2).CNTF concentration in the liquor filling the 4^th^ ventricle is ˜threefold increased 20 min after acute noxious stress. *n *=* *4 rats/group were used. \**P \< *0.05.CNTF infusion (4 μl, 6 ng/μl) in the 3^rd^ ventricle induces hypolocomotion. Dashed lines indicate the center--periphery boundary used. \**P \< *0.05, *n *=* *7/group. Representative traces of ambulation over a period of 10 min are shown.Data information: Data are expressed as means ± s.e.m. and were analyzed by either Student\'s *t*‐test (A1, B1, and C) or Mann--Whitney *U*‐test (F).](EMBJ-37-e100087-g004){#embj2018100087-fig-0002}

Ependymal cells also expressed *Cntf* mRNA (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}C), a neurotrophin implicated in neurogenesis and repair (Kazim & Iqbal, [2016](#embj2018100087-bib-0041){ref-type="ref"}). We validated these data by anti‐ciliary neurotrophic factor (CNTF) histochemistry (Severi *et al*, [2012](#embj2018100087-bib-0085){ref-type="ref"}; Fig [2](#embj2018100087-fig-0002){ref-type="fig"}D and D1), by RT--PCR in micropunches from the ventricular wall ([Appendix Fig S1D](#embj2018100087-sup-0001){ref-type="supplementary-material"}), and by comparing cultured neurons and astroglia ([Appendix Fig S1D1](#embj2018100087-sup-0001){ref-type="supplementary-material"}). High‐resolution imaging showed EGFP^+^ terminals in *Crh*‐*Ires*‐Cre::*egfp* mice in close apposition to CNTF^+^ ependymal cells (Fig [2](#embj2018100087-fig-0002){ref-type="fig"}D2). Because acute stress increases CRH^+^ synaptic input on ependymal cells (Fig [2](#embj2018100087-fig-0002){ref-type="fig"}A1), we measured whether this translates into CNTF being liberated into the cerebrospinal fluid ([Appendix Fig S1E](#embj2018100087-sup-0001){ref-type="supplementary-material"}). Indeed, an \~threefold increase in CNTF levels was observed 20 min after acute stress in liquor collected from the 4^th^ ventricle (59.04 ± 26.41 pg/ml in control vs. 220.27 ± 98.51 in stress, *\*P *\<* *0.05; Fig [2](#embj2018100087-fig-0002){ref-type="fig"}E). Acute stress invariably evokes characteristic defensive behaviors, with an initial period of immobility ("freezing") followed by hypolocomotion (Morilak *et al*, [2005](#embj2018100087-bib-0059){ref-type="ref"}; de Andrade *et al*, [2012](#embj2018100087-bib-0005){ref-type="ref"}; Niermann *et al*, [2017](#embj2018100087-bib-0062){ref-type="ref"}) used as key indicators. If CNTF volume transmission mediates acute stress responses, then CNTF infusion into the cerebrospinal fluid under ambient conditions ought to mimic stress‐induced behaviors. Indeed, intracerebroventricular (icv) CNTF infusion (4 μl, 6 ng/μl) in freely moving rats resulted in significant hypolocomotion (*P *\<* *0.05; Fig [2](#embj2018100087-fig-0002){ref-type="fig"}F). These data cumulatively suggest that stress‐activated CRH neurons initiate phasic CNTF release into the aqueductal system for action by volume transmission in adult brain.

CNTF activates tyrosine hydroxylase in norepinephrine neurons that project to the prefrontal cortex {#embj2018100087-sec-0005}
---------------------------------------------------------------------------------------------------

CNTF released into the aqueductal system might act at sites distant from its place of production. We inferred that any neuronal contingent responding to CNTF stimuli must directly be exposed to the cerebrospinal fluid, likely through dendrites targeting the ependymal surface, and express CNTF tyrosine kinase receptors (CNTFRs; Ip *et al*, [1993](#embj2018100087-bib-0039){ref-type="ref"}). The open‐source Allen brain atlas highlights CNTFR mRNA in the locus coeruleus (LC; Fig [3](#embj2018100087-fig-0003){ref-type="fig"}A). By using dual‐label histochemistry, we demonstrate that tyrosine hydroxylase (TH)^+^ processes targeting the overlaying ependymal surface of the 4^th^ ventricle ([Appendix Fig S2A](#embj2018100087-sup-0001){ref-type="supplementary-material"}) contain CNTFRs (Fig [3](#embj2018100087-fig-0003){ref-type="fig"}B and B1). We further integrated the LC into the neural circuitry responding to acute stress by showing stress‐induced c‐Fos immunoreactivity in this brain area (Fig [3](#embj2018100087-fig-0003){ref-type="fig"}C).

![CNTF activates tyrosine hydroxylase by phosphorylation in mouse and human locus coeruleus\
*Cntfr* mRNA expression in mouse locus coeruleus (LC, *white arrows*). Increasing mRNA content is indicated by a color gradient ranging from dark blue (low) to red (high). The ependymal surface as contact point with the 4^th^ ventricle is shown in blue. Scale bar = 100 μm.Hypothetical orientation of NE neurons with their dendrites emanating toward the 4^th^ ventricle. (B1) CNTF receptor (CNTFR) localization in tyrosine hydroxylase (TH)^+^ processes extending toward the ventricular wall (arrow marks *ventricular surface*). Scale bar = 10 μm.c‐Fos activation in LC 2 h after formalin stress. *Left:* Increased density of c‐Fos^+^ cells in the LC. Scale bar = 150 μm. *Right*: Quantitative data. \**P \< *0.05, *n *=* *4/group.Representative Western blots of *ex vivo* LC explants acutely exposed to recombinant CNTF (for 20 min) show increased TH (D1) and Erk1 (D2) phosphorylation (*n *≥* *3 samples/group). \**P \< *0.05.Intracerebroventricular infusion of *Cntf* siRNA blunts stress‐induced TH phosphorylation in the LC. (E1) Acute stress was triggered by injecting 4% PFA into a left hind paw unilaterally. Sampling followed 20 min later. \**P \< *0.05, *n *=* *8/group.Schematic diagram of the BDA‐based retrograde labeling of LC neurons projecting to the mPFC. (F1) Multiple‐labeling immunofluorescence detection of CNTFRs in a BDA^+^/TH^+^ neuron. *Solid arrowheads* point to perisomatic CNTFRs, and *open arrowheads* label BDA accumulation, while *asterisks* identify BDA^−^/TH^+^ neurons. Scale bar = 7 μm. (F2) Quantitative analysis of CNTFR density on the plasmalemmal surface of BDA^−^ vs. BDA^+^ NE neurons in *n *=* *4 rats. \**P \< *0.05.Graphical rendering of the experimental outline to test CNTF effects on NE neurons projecting to the mPFC. GCaMP6f was microinjected into the mPFC *in vivo* with exogenous CNTF (2 nM) applied to brain slices containing the LC 14 days later. (G1) Representative traces of GCaMP6f fluorescence changes in two NE neurons in response to bath‐applied CNTF (green shading). KCl (55 mM) was used as positive control.Data information: Data are expressed as means ± s.e.m. and were statistically evaluated using Student\'s *t*‐test (C, D1, D2, E1, F2).](EMBJ-37-e100087-g006){#embj2018100087-fig-0003}

TH is the rate‐limiting enzyme of NE production with its activity regulated by phosphorylation at Ser^31^ (but not Ser^40^; Zigmond *et al*, [1989](#embj2018100087-bib-0102){ref-type="ref"}; Dickson & Briggs, [2013](#embj2018100087-bib-0022){ref-type="ref"}; Tekin *et al*, [2014](#embj2018100087-bib-0094){ref-type="ref"}). Particularly, CNTF, like physical stressors (Ong *et al*, [2014](#embj2018100087-bib-0063){ref-type="ref"}), stimulates TH activity through Ser^31^ phosphorylation (Shi *et al*, [2012b](#embj2018100087-bib-0087){ref-type="ref"}). Here, we find that recombinant CNTF induces significant Ser^31^ phosphorylation of TH, along with prototypic Erk1 phosphorylation (Haycock *et al*, [1992](#embj2018100087-bib-0036){ref-type="ref"}) in cranial pons explants containing the LC (45 and 58% increase in the phosphorylated forms of TH and Erk, respectively, *\*P *\<* *0.05; Fig [3](#embj2018100087-fig-0003){ref-type="fig"}D--D2; [Appendix Fig S2B](#embj2018100087-sup-0001){ref-type="supplementary-material"}). When applying subcutaneous formalin stress, Ser^31^ phosphorylation of TH was transient (\~twofold at 20 min, *P *\<* *0.05) and eluded its Ser^40^ residue, which seems unrelated to augmenting NE synthesis upon pain‐induced stress (Ong *et al*, [2014](#embj2018100087-bib-0063){ref-type="ref"}; [Appendix Fig S2C and C1](#embj2018100087-sup-0001){ref-type="supplementary-material"}). To substantiate that ventricular ependyma is the source of CNTF to induce TH activity in LC, we performed site‐directed *Cntf* silencing through icv siRNA infusion (Fig [3](#embj2018100087-fig-0003){ref-type="fig"}E). We then harvested LC tissues from animals that had been subjected to acute formalin stress 72 h after siRNA application and find the complete lack of Ser^31^ phosphorylation of TH (Fig [3](#embj2018100087-fig-0003){ref-type="fig"}E1). In sum, we suggest that liquor‐borne CNTF modulates NE output from the LC upon acute stress particularly since neither neurons nor glia prepared from cranial pons can produce CNTF and act as a local (and alternative) source ([Appendix Fig S1D1](#embj2018100087-sup-0001){ref-type="supplementary-material"}).

NE neurons innervate the entire cortical mantle with particularly dense efferent projections to the PFC (Porrino & Goldman‐Rakic, [1982](#embj2018100087-bib-0069){ref-type="ref"}; Nakane *et al*, [1994](#embj2018100087-bib-0061){ref-type="ref"}). PFC‐projecting NE neurons were recently sub‐classified functionally, being indispensable for behavioral flexibility (Uematsu *et al*, [2017](#embj2018100087-bib-0097){ref-type="ref"}). Considering the hypolocomotion evoked by CNTF infusion, we posit that those NE neurons that innervate the PFC might be particularly endowed with CNTFRs. We have tested this hypothesis by microinjecting biotinylated dextran amine, serving as retrograde tracer, into the medial PFC (mPFC) and quantifying CNTFR density on NE neurons 7 days later (Fig [3](#embj2018100087-fig-0003){ref-type="fig"}F and F1). Indeed, we find an \~threefold enrichment in CNTFRs in NE neurons that provide efferentation to the mPFC (Fig [3](#embj2018100087-fig-0003){ref-type="fig"}F2). Finally, we tested whether mPFC‐targeting NE neurons respond to CNTF by injecting AAVs encoding the Ca^2+^ indicator GCaMP6 in a Cre‐dependent manner into the PFC (Fig [3](#embj2018100087-fig-0003){ref-type="fig"}G). For this, we have developed secretagogin (*Scgn*)‐Cre mice ([Appendix Fig S2D and D1](#embj2018100087-sup-0001){ref-type="supplementary-material"}) because secretagogin, an EF‐hand tetra‐Ca^2+^‐sensor protein (Wagner *et al*, [2000](#embj2018100087-bib-0099){ref-type="ref"}; Alpár *et al*, [2012](#embj2018100087-bib-0003){ref-type="ref"}; Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}), is abundantly expressed in NE neurons residing in LC (Mulder *et al*, [2009](#embj2018100087-bib-0060){ref-type="ref"}). Fourteen days after viral GCaMP6 delivery, we used Ca^2+^ imaging to monitor whether CNTF superfusion affects NE neurons *ex vivo*. As Fig [3](#embj2018100087-fig-0003){ref-type="fig"}G1 shows, CNTF induced Ca^2+^ influx in NE neurons projecting to the mPFC. Thus, we suggest that liquor‐borne CNTF can modulate NE output in the mPFC upon acute stress.

Secretagogin regulates tyrosine hydroxylase phosphorylation in NE neurons {#embj2018100087-sec-0006}
-------------------------------------------------------------------------

We next interrogated whether CNTFR‐dependent TH phosphorylation may be mediated by a hierarchical Erk1‐dependent signaling cascade (Haycock *et al*, [1992](#embj2018100087-bib-0036){ref-type="ref"}). We inferred that the precise timing and duration of any such activation step is likely reliant on coincidence detectors, such as Ca^2+^‐sensor proteins (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}; Fig [4](#embj2018100087-fig-0004){ref-type="fig"}A). As such, NE neurons in both rodents (Figs [4](#embj2018100087-fig-0004){ref-type="fig"}B--B2 and [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}A--D) and humans (Fig [5](#embj2018100087-fig-0005){ref-type="fig"}A and A1) meet these criteria since they express secretagogin (Figs [4](#embj2018100087-fig-0004){ref-type="fig"}B1 and [5](#embj2018100087-fig-0005){ref-type="fig"}A1). Secretagogin is neuron‐specific in mammalian brain (Mulder *et al*, [2009](#embj2018100087-bib-0060){ref-type="ref"}) and also coordinates acute stress‐induced fast CRH release from parvocellular neurons at the median eminence (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}). Besides somatic expression (Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}C), we localized secretagogin to both NE dendrites (Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}C1) and axons (Figs [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}D and [EV4](#embj2018100087-fig-0004ev){ref-type="fig"}B), including synaptosomes (Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}F), suggesting that its interactome could modulate NE activity even at locations positioned distally from NE perikarya. We then used neuropeptide Y and enkephalin to mark subsets of TH^+^ neurons (Finley *et al*, [1981](#embj2018100087-bib-0028){ref-type="ref"}; Everitt *et al*, [1984](#embj2018100087-bib-0025){ref-type="ref"}) to show that secretagogin labeled both NE subsets in the LC (Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}F, enkephalin not shown). This suggests a functional relationship to TH itself rather than to a specific neuromodulatory peptide.

![Secretagogin recruits Erk1 for tyrosine hydroxylase phosphorylation in mouse noradrenergic neurons\
Graphical rendering of the proposed intracellular signaling cascade based on reports placing Erk1 as a function determinant for tyrosine hydroxylase (TH) by phosphorylation (Tekin *et al*, [2014](#embj2018100087-bib-0094){ref-type="ref"}).Histochemical detection of secretagogin (SCGN) in mouse LC. (1) depicts the dense meshwork of local fibers, likely dendrites, emanating toward the 4^th^ ventricle (4V). (B1) Secretagogin co‐localizes with TH in many (*solid arrowheads*) but not all (*open arrowheads*) neurons in the LC. (B2) Micropunches of native tissue followed by Western analysis confirm the presence of both TH and SCGN in the LC. Scale bars = 100 μm (B), 30 μm (B *inset*), and 10 μm (B1).TH phosphorylation upon acute CNTF infusion into the 3^rd^ ventricle in freely moving *Cntf* ^−/−^, *Scgn* ^−/−^ and wild‐type mice. *n *=* *10/group; \**P \< *0.05 vs. wild‐type. Data were normalized to controls not exposed to formalin stress. Representative Western blots are shown in Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}G.Recombinant CNTF induces TH phosphorylation at Ser^31^ in INS‐1E cells, which co‐express SCGN, Erk1, and TH. RNAi silencing of *Scgn* abolishes TH activation (from triplicate experiments; \**P \< *0.05).Recombinant CNTF also induces Erk1 phosphorylation in a *Scgn*‐dependent manner in INS‐1E cells (from triplicate experiments; \**P \< *0.05).Immunoprecipitation (IP) using an anti‐secretagogin antibody as bait led to the co‐elution of Erk1 in mouse brainstem.Formalin stress increases Ser^31^‐phosphorylated TH levels in the LC of wild‐type but not *Scgn* ^−/−^ mice. *n *=* *5/genotype; \**P \< *0.05.Microinjection of AAV particles carrying activating (hM3Dq) and inactivating (hM4Di) DREADD constructs in *Scgn*‐Cre mice. Histochemistry shows site‐directed mCherry expression in the LC 14--28 days later. Scale bar = 250 μm. (H1) *Left*: CNO‐induced freezing in hM3Dq but not hM4Di carriers. Data in box plots represent medians and 10^th^, 25^th^, 75^th^, and 90^th^ percentiles. \*\**P \< *0.01 vs. control or hM4Di, *n* ≥ 4 animals/group. *Right*: Representative trajectories in the open field during 5 min.Data information: Data are expressed as means ± s.e.m. and were statistically analyzed by either Student\'s *t*‐test (C, D, E, G) or ANOVA (general linear model; H1).](EMBJ-37-e100087-g008){#embj2018100087-fig-0004}

![Secretagogin expression in rodent brain stem (related to Fig [4](#embj2018100087-fig-0004){ref-type="fig"})\
A, A1Labeling specificity of our anti‐secretagogin antibody was verified in *Scgn* ^−/−^ mice (A1). These experiments also showed that tyrosine hydroxylase (TH)^+^ LC neurons (\*) co‐express secretagogin in wild‐type (*solid arrowheads*) but not null mice (*open arrowheads*). Scale bars = 200 μm (low‐power micrographs, *left*) and 10 μm (high‐resolution insets, *right*).BSecretagogin^+^ neurons populate the locus coeruleus (LC) in the rat. Solid red circles pinpoint the general location of perikarya, while fine lines correspond to axons coursing toward the surface (4^th^ ventricle).C, C1Secretagogin was expressed in both the somata (*arrowheads*; C) and dendrites (*arrowheads*; C1) of most TH^+^ neurons in the rat, too. Scale bars = 30 μm.DSecretagogin is localized to axons (*arrowheads*) in the rat. (D) Dorsal nucleus of vagus (nX), "2" shows the nucleus at high resolution. Scale bars = 200 μm (D), 30 μm (2).ESecretagogin (SCGN) is enriched in the synaptosomal fraction prepared from the mouse prefrontal cortex, lending additional support for its axonal localization. Synaptophysin (SYP) was used to control the enrichment of presynaptic proteins.FSecretagogin^+^ neurons can co‐express neuropeptide Y (NPY) in the LC of the rat. Open and solid *arrowheads* indicate the lack and existence of NPY co‐localization in adjacent neurons, respectively. Scale bars = 10 μm.GRepresentative Western blots from *Cntf* ^−/−^, *Scgn* ^−/−^, and wild‐type mice with or without intracerebroventricular CNTF treatment.H, H1INS‐1E cells were used as a cellular model exclusively because of their native co‐expression of CNTF receptor‐α (CNTFRα), tyrosine hydroxylase (TH), secretagogin (SCGN), and extracellular signal‐regulated kinase 1/2 (Erk1/2). Red arrows label target proteins at their predicted sizes. Multiple bands likely represent splice variants, posttranslational modifications, or multimers. Antibodies were also validated histochemically often using knock‐out tissues.ISecretagogin, phospho‐Ser^31^‐TH, phospho‐Erk1, and total Erk1 expression in INS‐1E cells stimulated with CNTF with/without concomitant silencing of secretagogin (*Scgn*) gene expression (for 48 h). Note the lack of Erk1 phosphorylation upon genetic inactivation of secretagogin.JSignificant reduction of secretagogin (SCGN) protein levels upon acute RNAi‐mediated gene silencing *in vitro* (for 48 h). CNTF exposure did not affect the efficacy of gene silencing. Experiments were performed in triplicate; \**P \< *0.05 (Student\'s *t*‐test).KUnchanged tyrosine hydroxylase (TH) expression in wild‐type and *Scgn* ^−/−^ mice regardless of formalin‐induced stress ("+PFA"). These data validate our suggestion on protein phosphorylation, rather than degradation, being a critical step in secretagogin\'s mechanism of action. ns, non‐significant (Student\'s *t*‐test). Data are from *n \> *4 mice/genotype.Data information: Data are expressed as means ± s.e.m.](EMBJ-37-e100087-g005){#embj2018100087-fig-0002ev}

![Tyrosine hydroxylase phosphorylation in humans experiencing severe stress\
The LC contains secretagogin^+^ neurons in humans, as well. (2) depicts secretagogin‐labeled perikarya residing in a dense meshwork of local fibers, likely dendrites. (A1) Secretagogin co‐exists with TH in most neurons *(solid arrowheads*). Scale bars = 350 μm (A), 120 μm (A/2), and 12 μm (A1).Total TH levels and their phosphorylation at Ser^31^ in suicidal subjects relative to age‐matched controls \[*n *=* *6 (suicide) and *n *=* *7 (controls)\]. \**P \< *0.05. Representative Western blots are shown in Fig [EV4](#embj2018100087-fig-0004ev){ref-type="fig"}A.Total and Ser^31^‐phosphorylated TH in acute heart failure (AHF) in human subjects. Representative Western blot. (C1) Data from *n *=* *7 subjects with acute heart failure and *n *=* *6 controls. \**P \< *0.05.Immunoprecipitation (IP) using an anti‐secretagogin antibody as bait revealed increased secretagogin (SCGN)‐Erk1 interaction in LC micropunches after AHF. nt IgG, non‐targeting IgG. Representative immunoblot is shown. Experiments were performed in triplicate.Data information: Data are expressed as means ± s.e.m. and were analyzed by Student\'s *t*‐test (B, C).](EMBJ-37-e100087-g010){#embj2018100087-fig-0005}

We sought to address causality between liquor‐borne CNTF, secretagogin, and TH phosphorylation at its Ser^31^ residue by acute icv administration of CNTF in freely moving *Cntf* ^−/−^, *Scgn* ^−/−^, and wild‐type mice. We reasoned that *Cntf* ^−/−^ mice could respond like wild‐type littermates with CNTFR signaling in NE neurons remaining signal competent. In turn, *Scgn* ablation could occlude CNTF‐induced TH phosphorylation by disrupting the signal transduction machinery downstream from CNTFRs (Fig [4](#embj2018100087-fig-0004){ref-type="fig"}A). As such, we find Ser^31^‐phosphorylated TH in *Cntf* ^−/−^ at levels equivalent to those in wild‐type mice (\~1.5‐fold increase; Figs [4](#embj2018100087-fig-0004){ref-type="fig"}C and [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}G). In contrast, CNTF infusion was ineffective to modulate TH phosphorylation in *Scgn* ^−/−^ mice (Fig [4](#embj2018100087-fig-0004){ref-type="fig"}C). These results provide genetic evidence for secretagogin linking CNTFR activation to TH phosphorylation in NE neurons.

To further dissect how secretagogin regulates TH phosphorylation, we first identified INS‐1E cells (Merglen *et al*, [2004](#embj2018100087-bib-0055){ref-type="ref"}) as a cellular model in which CNTFR, TH*,* secretagogin, and Erk1 are natively co‐expressed (Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}H and H1). We then showed that RNAi‐mediated *Scgn* silencing in INS‐1E cells occludes CNTF‐induced TH phosphorylation at Ser^31^ (Figs [4](#embj2018100087-fig-0004){ref-type="fig"}D, and [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}I and J). Likewise, CNTF‐induced Erk1 phosphorylation was abolished by *Scgn* knock‐down (Fig [4](#embj2018100087-fig-0004){ref-type="fig"}E). Conspicuously, immunoprecipitation for secretagogin led to Erk1 co‐precipitation in cranial pons homogenates (Fig [4](#embj2018100087-fig-0004){ref-type="fig"}F), suggesting that secretagogin could modulate TH phosphorylation through protein--protein interactions with Erk1. We then tested whether secretagogin regulates TH phosphorylation *in vivo* by subjecting *Scgn* ^−/−^ and wild‐type littermate mice to formalin stress and assaying Ser^31^ phosphorylation in their brainstem. Stress‐induced TH phosphorylation did not occur in *Scgn* ^−/−^ mice (*P *=* *0.89 control vs. stress) as opposed to their wild‐type littermates (43% increase, *P *\<* *0.05 vs. *Scgn* ^−/−^ mice; Fig [4](#embj2018100087-fig-0004){ref-type="fig"}G) when, notably, *Scgn* ablation did not change total TH levels (Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}K). In sum, our *in vivo* and *in vitro* data mechanistically place secretagogin into a hierarchical signal transduction cascade controlling TH phosphorylation in NE neurons.

If secretagogin^+^ NE neurons that project to the PFC drive stress‐induced defense, then their chemogenetic manipulation could manifest as freezing/hypolocomotion in a novel environment. We have tested this hypothesis by injecting AAV particles carrying Cre‐dependent DREADD expression systems for neuronal activation (hM3Dq; Alexander *et al*, [2009](#embj2018100087-bib-0002){ref-type="ref"}) or inactivation (hM4Di; Armbruster *et al*, [2007](#embj2018100087-bib-0007){ref-type="ref"}) into the LC of *Scgn*‐Cre mice (Fig [4](#embj2018100087-fig-0004){ref-type="fig"}H). Once placing CNO pre‐treated animals (10 min; 2 mg/kg) into an open field, we find that chemogenetic NE activation induces freezing, rendering the animals persistently immobile (Figs [4](#embj2018100087-fig-0004){ref-type="fig"}H1 and Movies [EV1](#embj2018100087-sup-0003){ref-type="supplementary-material"}, [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}A; [EV2](#embj2018100087-sup-0004){ref-type="supplementary-material"} and [EV3](#embj2018100087-sup-0005){ref-type="supplementary-material"}). In contrast, hM4Di‐treated animals remained mobile (Fig [4](#embj2018100087-fig-0004){ref-type="fig"}H1). We then repeated this experiment by exposing subsets of mice to formalin stress and CNO infusion 15--20 min prior to recordings. Here, hM3Dq‐treated animals that underwent formalin stress exhibited a more uniform freezing response (Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}A and A1) suggesting the formalin‐induced reinforcement of CNO action. By showing that hM3Dq‐carrier mice lacked an anxiogenic response when subjected to an elevated plus maze task (Harkany *et al*, [1999](#embj2018100087-bib-0035){ref-type="ref"}; Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}B), we excluded that changes in open‐field activity were due to anxiety.

![Behavioral output upon chemogenetic manipulation and in *Scgn* ^−/−^ mice (related to Fig [4](#embj2018100087-fig-0004){ref-type="fig"})\
A, A~1~Open‐field performance in mice with DREADD constructs expressed in NE neurons with (or without) formalin exposure 20 min prior to behavioral testing. Open labels correspond to values in each individual tested. \**P \< *0.05 vs. control and hM4Di groups.BData from elevated plus maze, including time spent on open and in the center of the maze 15--20 min after activating DREADD constructs in NE neurons. Open labels correspond to values in each individual tested.C*Scgn* ^−/−^ mice exhibit normal sensory (pain) thresholds as measured in the von Frey test. (C1, C2) Noxious acute stress in *Scgn* ^−/−^ mice vs. wild‐type littermates biases sensory behaviors, including the pinna reflex (C1) and paw withdrawal (C2) (*n *=* *5--7/genotype; \**P \< *0.05).D*Scgn* ^−/−^ mice accommodate in a closed environment similar to their wild‐type littermates (*P \> *0.1, D). In contrast, *Scgn* ^−/−^ mice exhibit only minimal freezing ("latency", D1) in response to repeated stochastic and unavoidable foot‐shock. Data represent latency values averaged from five foot‐shock sessions. Note that neither the extent of exploratory behavior ("travelled distance") nor the time spent in the center of the closed chamber is different, reinforcing stress resilience rather than accelerated habituation. *n *=* *3 mice/group (\**P \< *0.05 for "latency"). (D2) Cumulative heat‐traces of animal movements during representative trials.Data information: Data are expressed as means ± s.e.m. Behaviors in the open‐field and elevated plus maze tests were evaluated by ANOVA using a general linear model with genotype, sex, and treatment being fixed factors followed by appropriate group comparisons. Pairs of treatment groups were analyzed using the Mann--Whitney *U*‐test.](EMBJ-37-e100087-g007){#embj2018100087-fig-0003ev}

*Scgn* ^−/−^ mice are resilient to acute stress {#embj2018100087-sec-0007}
-----------------------------------------------

Next, we argued that *Scgn* ^−/−^ mice could be resilient to acute stress because of their blunted NE production and, consequently, NE inactivity in PFC when exposed to stress acutely. Considering that NE inputs to the mPFC drive behavioral flexibility (Uematsu *et al*, [2017](#embj2018100087-bib-0097){ref-type="ref"}), we opted for behavioral paradigms that reveal sensory components of stress sensitivity without being reliant on enforcement or association (Tovote *et al*, [2015](#embj2018100087-bib-0096){ref-type="ref"}). Since secretagogin is expressed in sensory dorsal root ganglia (Shi *et al*, [2012a](#embj2018100087-bib-0086){ref-type="ref"}), we first verified that *Scgn* ^−/−^ mice had unchanged sensory thresholds in the von Frey filament test, as compared to wild‐type littermates (*P *=* *0.19; Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}C). Thereafter, we showed that *Scgn* ^−/−^ mice produce reduced escape responses when triggering their pinna reflex (Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}C1) or exposing them to toe pinch (*P *\<* *0.05 vs. wild‐type littermates; Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}C2). Additionally, *Scgn* ^−/−^ mice do not bite when provoked \[0.33 ± 0.17 (wild‐type) vs. 0.92 ± 0.21 (*Scgn* ^−/−^, biting index, *P *\<* *0.05)\]. Lastly, *Scgn* ^−/−^ mice habituate to a novel environment indistinguishable from wild‐type controls (Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}D and D1). Nevertheless, when delivering a random sequence of unavoidable foot‐shocks, their period of immobility ("freezing") is significantly reduced as compared to wild‐type littermates (*P *\<* *0.05; Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}D1). Since neither the distance nor the pattern of their mobility differs significantly from control mice (Fig [EV3](#embj2018100087-fig-0003ev){ref-type="fig"}D and D2), we conclude that genetic ablation of *Scgn* could impede NE network determinants of stress‐associated behaviors to produce resilience.

Severe pathogenic stress induces TH phosphorylation in human LC {#embj2018100087-sec-0008}
---------------------------------------------------------------

If stress‐induced TH phosphorylation is of pathophysiological significance, then it might be detected in humans with severe acute stress (and associated pain). In support of this hypothesis, we find increased Ser^31^ phosphorylation *post‐mortem* (with concomitant increases in TH content itself) in LC micropunches (Palkovits, [1973](#embj2018100087-bib-0066){ref-type="ref"}) in suicide subjects (108 and 44% increase in native and pSer^31^‐phosphorylated TH levels, respectively, *P *\<* *0.05; Figs [5](#embj2018100087-fig-0005){ref-type="fig"}B and [EV4](#embj2018100087-fig-0004ev){ref-type="fig"}A), as well as those succumbing to acute heart failure (150 and 129% increase in total and Ser^31^‐phosphorylated TH levels relative to controls, respectively, *P *\<* *0.05; Fig [5](#embj2018100087-fig-0005){ref-type="fig"}C and C1). Moreover, when performing immunoprecipitation with secretagogin as bait in *post‐mortem* LC specimens of subjects with acute heart failure, we find substantially higher Erk1 content in the eluent fraction, as compared to control subjects and non‐targeting IgG controls (Fig [5](#embj2018100087-fig-0005){ref-type="fig"}D). In sum, these data suggest that stress‐induced NE sensitization is a mechanism conserved among mammalian species, including humans.

![Secretagogin expression in human brain stem (related to Fig [5](#embj2018100087-fig-0005){ref-type="fig"})\
pSer^31^‐TH and TH expression in suicide individuals. Numerical data are shown in Fig [5](#embj2018100087-fig-0005){ref-type="fig"}B.Secretagogin^+^ neurons densely populate the dorsal nucleus of vagus (nX) and the A7 field in the human brainstem. Scale bars = 1 mm (nX overview, *left*), 150 μm (inset "2"), and 70 μm (A7 group, *right*).](EMBJ-37-e100087-g009){#embj2018100087-fig-0004ev}

Secretagogin controls NE‐induced neuronal excitability in the prefrontal cortex {#embj2018100087-sec-0009}
-------------------------------------------------------------------------------

Brainstem NE neurons regulate alertness and emotional flexibility (Uematsu *et al*, [2017](#embj2018100087-bib-0097){ref-type="ref"}) through their direct efferents to the mPFC (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}A), which is identified as the cortical "hub" for escape behaviors (McNaughton & Corr, [2004](#embj2018100087-bib-0054){ref-type="ref"}; Wu *et al*, [2016](#embj2018100087-bib-0100){ref-type="ref"}; Schwabe, [2017](#embj2018100087-bib-0081){ref-type="ref"}). Therefore, and based on our experimental results, we posited that the mPFC is the final element of a hypothalamus‐LC‐PFC tripartite circuit that drives stress‐induced behaviors. In mice, we focused on the infra‐ and prelimbic cortices, which correspond to the ventromedial area of the mPFC in humans and are connected to the hypothalamus and amygdala to regulate emotional actions (Arnsten, [2009](#embj2018100087-bib-0008){ref-type="ref"}). First, we used BDA‐based anterograde tract tracing (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}A) to show that TH^+^ efferents to the mPFC contain Ser^31^‐phosphorylated TH (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}B and B1), which is typically present in *en‐passant* boutons. For secretagogin to modulate TH activity in NE axons, it ought to be co‐expressed with pSer^31^‐TH in the mPFC. Indeed, Western analysis suggests that secretagogin--TH regulatory interactions could dominate in the mPFC (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}C, more so than in, e.g., somatosensory areas) with its presence in synaptosomal fractions reinforcing presynaptic modulation (Fig [EV2](#embj2018100087-fig-0002ev){ref-type="fig"}F). Moreover, *Scgn* ^−/−^ mice failed to display Ser^31^ phosphorylation of TH in the mPFC relative to wild‐type littermates \[−18% (*Scgn* ^−/−^) vs. +30% (wild‐type), *P *\<* *0.05; Fig [6](#embj2018100087-fig-0006){ref-type="fig"}D and D1\]. Since stress‐induced TH activation by phosphorylation supports NE synthesis *in loco*, we hypothesized that NE signaling is chronically impaired in *Scgn* ^−/−^ mice and the lack of a stress‐induced NE surge precludes stress‐induced behavioral phenotypes. To this end, we determined cortical NE content in *Scgn* ^−/−^ and wild‐type mice exposed to acute stress. Indeed, peripheral formalin injection increased NE production in the mPFC of wild‐type animals \[0.25 ± 0.02 (control) vs. 0.31 ± 0.02 (stress) NE μg/mg tissue at 120 min after stress induction (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}E)\]. In turn, *Scgn* ^−/−^ mice failed to produce a stress‐induced NE surge \[0.28 ± 0.02 (control) vs. 0.27 ± 0.03 NE μg/mg tissue, *P *=* *0.73; Fig [6](#embj2018100087-fig-0006){ref-type="fig"}E\]. These changes did not affect, e.g., the somatosensory cortex and only perturbed NE but neither dopamine nor 3,4‐dihydroxyphenylacetic acid (DOPAC) levels (Fig [EV5](#embj2018100087-fig-0005ev){ref-type="fig"}H). These data suggest that NE production is impaired in the mPFC of *Scgn* ^−/−^ mice, which could underpin behavioral insensitivity to acute stress.

![Secretagogin gates noradrenergic activity in PFC\
Schema of noradrenergic projections to the medial prefrontal cortex (mPFC) used for tract tracing and the analysis of axonal tyrosine hydroxylase (TH) phosphorylation. (1) Biotinylated dextran amine (BDA) injected into the mouse LC led to (2) BDA‐labeled TH^+^ axons contacting pyramidal cells (*upper*) and interneurons (*lower*) in the mPFC (*open arrowheads*). Scale bars = 100 μm (1) and 10 μm (2).TH^+^ axons (*open arrowheads*, B) contained TH phosphorylated at Ser^31^ (*open arrowheads*, B1). Scale bars = 10 μm (B, B1/left) and 2 μm (B1/right).Secretagogin (SCGN) is abundantly co‐expressed with Ser^31^‐phosphorylated TH in mPFC (note marginal expression in somatosensory cortex). cbl, cerebellum; hp, hippocampus; mPFC, medial prefrontal cortex; S1, primary somatosensory cortex.Formalin stress induces TH phosphorylation in the mPFC of wild‐type but not *Scgn* ^−/−^ mice; *n *=* *5/genotype; \**P \< *0.05.*Scgn* ^−/−^ mice fail to produce NE in mPFC upon acute stress (*n* ≥ 4/group). Figure [EV5](#embj2018100087-fig-0005ev){ref-type="fig"}H is referred to for data on unchanged dopamine and DOPAC levels. Note that acute formalin stress failed to significantly elevate NE in the somatosensory cortex (*P *=* *0.259) even if a differential response to stress between wild‐type and *Scgn* ^−/−^ mice is noticeable. \**P \< *0.05.NE superfusion *ex vivo* increases the excitability of layer (L) 5 pyramidal cells in the mPFC of *Scgn* ^−/−^ mice relative to wild‐type littermates. (F1) Quantitative data. \**P \< *0.05, *n *≥* *3 mice/genotype.Experimental protocol to test whether optogenetic activation of NE efferents to the mPFC is sufficient to increase cortical network excitability. Fourteen days after AAV infusion, experiments were performed in acute brain slices spanning the mPFC using 470 and 535 nm (control) excitation wavelengths.Biocytin‐filled L5 pyramidal neuron receives channelrhodopsin‐2/mCherry‐containing NE inputs. *Open arrowheads* point to varicosities apposing pyramidal dendrites. Scale bar = 100 μm.Representative images of heightened glutamatergic responses in L5 pyramidal cells upon 470‐nm light excitation (blue shading). Gray traces (top) show the lack of excitability when exposed to light at 535 nm. (I1) Amplitude of postsynaptic currents at both wavelengths. \**P \< *0.05 vs. control at 535 nm. (I2) Light‐induced response frequencies. \*\**P \< *0.01 vs. control at 535 nm.Data information: Data are expressed as means ± s.e.m. and were statistically tested by Student\'s *t*‐test (D1, E) or one‐way ANOVA (F1, I1, I2).](EMBJ-37-e100087-g012){#embj2018100087-fig-0006}

![Electrophysiological properties of layer 5 pyramidal cells in the mPFC of *Scgn* ^−/−^ vs. wild‐type mice (related to Fig [6](#embj2018100087-fig-0006){ref-type="fig"})\
Representative current‐clamp recordings showing significantly hyperpolarized resting membrane potentials of layer (L) 5 pyramidal cells in the mPFC of *Scgn* ^−/−^ mice immediately upon membrane rupture (see panel C for quantitative data).Spontaneous postsynaptic currents in *Scgn* ^−/−^ mice. Neurons were clamped at positive voltages to preferentially resolve excitatory postsynaptic currents. Note the markedly increased frequency of postsynaptic excitation in *Scgn* ^−/−^ mice.Quantitative demonstration of a negative shift in neuronal resting membrane potential in *Scgn* ^−/−^ pyramidal cells; \*\**P \< *0.01, *n *=* *33 (control) vs. *n *=* *18 (*Scgn* ^−/−^).Action potential parameters for L5 pyramidal cells in *Scgn* ^−/−^ mice vs. wild‐type littermates. (D) While action potential threshold was significantly reduced, neither its amplitude (D1) nor its half‐width changed in *Scgn* ^−/−^ cells (D2). \**P \< *0.05, *n *=* *23 (control) vs. *n *=* *16 (*Scgn* ^−/−^).Quantitative depiction of spontaneous postsynaptic currents (sPSCs) isolated as in panel (B). Note a tendency toward an increase in sPSC frequency in *Scgn* ^−/−^ cells. Each data point represents the median value (pA) of recording sweeps per cell. *n *=* *8 (control) vs. *n *=* *7 (*Scgn* ^−/−^).Membrane depolarization upon superfusion with 10 μM norepinephrine. On average, *Scgn* ^−/−^ neurons produced larger responses than their wild‐type counterparts. \**P \< *0.05, *n *=* *15 (control) vs. *n *=* *13 (*Scgn* ^−/−^).Afterdepolarization evoked by 2‐s stimulus in the presence of NE with each neuron pre‐clamped to −60 mV. *n *=* *8 (control) vs. *n *=* *7 (*Scgn* ^−/−^).Tissue levels of dopamine (DA) and 3,4‐dihydroxyphenylacetic acid (DOPAC), its major metabolite, in the medial prefrontal and somatosensory cortices of wild‐type and *Scgn* ^−/−^ mice that optionally underwent acute formalin stress. The stress‐induced increase in tissue norepinephrine (NE) content in wild‐type but not *Scgn* ^−/−^ mice is shown in Fig [6](#embj2018100087-fig-0006){ref-type="fig"}E. Data are from *n \> *4 animals/group.Data information: Results in panels (C, D, and F) were statistically analyzed by one‐way ANOVA.](EMBJ-37-e100087-g011){#embj2018100087-fig-0005ev}

If the lack of NE inputs to the mPFC of *Scgn* ^−/−^ mice is functionally significant, then altered excitability of pyramidal neurons might be expected to ensue. *Scgn* ^−/−^ layer 5 pyramidal cells exhibited significantly hyperpolarized resting membrane potentials (Fig [EV5](#embj2018100087-fig-0005ev){ref-type="fig"}A--C) and lowered voltage thresholds to generate action potentials (APs; Fig [EV5](#embj2018100087-fig-0005ev){ref-type="fig"}D--D2) *ex vivo*, suggesting their increased excitability. We also found that *Scgn* ^−/−^ pyramidal cells are increasingly sensitive to NE (10 μM) applied exogenously \[2.5 ± 0.7 mV (wild‐type) vs. 8.1 ± 2.1 (*Scgn* ^−/−^), *P *\<* *0.05; Figs [6](#embj2018100087-fig-0006){ref-type="fig"}F and F1, and [EV5](#embj2018100087-fig-0005ev){ref-type="fig"}E--G\], which we interpret as network sensitization to, and resetting of inherent flexibility toward the lifelong lack of tonic NE triggers. This notion is supported by marked increases in afterdepolarization effects on electrical self‐stimulation in the presence of NE (Figs [6](#embj2018100087-fig-0006){ref-type="fig"}F and [EV5](#embj2018100087-fig-0005ev){ref-type="fig"}G). We then employed an optogenetic approach to confirm that the activation of secretagogin‐expressing NE neurons in the LC is sufficient to reset mPFC network excitability (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}G). By introducing channelrhodopsin into NE neurons in *Scgn*‐Cre mice, we labeled PFC projections 14--17 days later (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}H). Since NE does not induce electrogenic currents *per se* but instead lowers the excitation threshold for glutamate through metabotropic α‐adrenergic receptors (Ramos & Arnsten, [2007](#embj2018100087-bib-0070){ref-type="ref"}; Santana *et al*, [2013](#embj2018100087-bib-0078){ref-type="ref"}), single short‐lived excitation pulses were without effect (data not shown). However, when using 30‐s laser excitation at 470 nm (but not 535 nm), repetitive high‐amplitude synaptic currents (9/15 cells; Fig [6](#embj2018100087-fig-0006){ref-type="fig"}I, *upper trace*) or activation of an inward current in the 30--150 pA range (3/15 cells; Fig [6](#embj2018100087-fig-0006){ref-type="fig"}I, *lower trace*) was recorded in layer 5 pyramidal cells (Fig [6](#embj2018100087-fig-0006){ref-type="fig"}I--I2). No such event was recorded under non‐stimulated conditions. These data show that secretagogin selectively co‐exists in the mPFC where it can control NE release onto pyramidal cells to modulate network output. Since NE neurotransmission is increased in stress, mediates cortical excitability in chronic states (Arnsten, [2009](#embj2018100087-bib-0008){ref-type="ref"}), and underpins fight/flight behaviors (Bremner *et al*, [2008](#embj2018100087-bib-0014){ref-type="ref"}), our results uncover a multimodal pathway that combines volume and synaptic neurotransmission to modulate excitatory output commands from the PFC.

Discussion {#embj2018100087-sec-0010}
==========

Collectively, we demonstrate the existence of a multimodal signaling pathway including both synaptic signaling and volume transmission from ependymal cells via the cerebrospinal fluid to maintain NE‐induced cortical excitability over prolonged periods. This pathway bypasses classical anatomical units of ascending sensory pathways (spinal, thalamic, and somatosensory cortical nodes) to express post‐traumatic vigilance. At the molecular level, and alike the HPA axis, CRH (Swanson & Sawchenko, [1980](#embj2018100087-bib-0089){ref-type="ref"}), secretagogin (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}), and NE (Korf *et al*, [1973](#embj2018100087-bib-0044){ref-type="ref"}) are used as mediators yet through the recruitment of novel cellular interactions for effective modulation of mPFC output. Moreover, our results suggest that CRH neurons might simultaneously orchestrate HPA activation and cortical excitability, which can be an advantage to overcome metabolic restrictions at the periphery.

Acute stress triggers a complex set of behaviors, which substantially differ in their magnitude and repertoire dependent on the context and duration. Consequently, substantial variations have been recorded in the extent, temporal dynamics, and connectivity diagrams of the neuronal circuits that underpin responses to stressful stimuli; e.g., hunger and fasting (but also overfeeding) activates proopiomelanocortin, neuropeptide Y, and glutamate (VGLUT2^+^) neurons in the arcuate nucleus of the hypothalamus through circulating hormones (Sternson *et al*, [2005](#embj2018100087-bib-0088){ref-type="ref"}; Campbell *et al*, [2017](#embj2018100087-bib-0016){ref-type="ref"}; Fenselau *et al*, [2017](#embj2018100087-bib-0026){ref-type="ref"}), and aggression toward (and defense against) an intruder activates the ventromedial hypothalamus (Lin *et al*, [2011](#embj2018100087-bib-0047){ref-type="ref"}), while maternal behaviors are executed by galanin‐containing neurons of the medial preoptic area (Kohl *et al*, [2018](#embj2018100087-bib-0043){ref-type="ref"}). Regardless of the cellular identity of the primary responder network, stress‐related command is executed by CRH neurons of the PVN, which are activated by ascending glutamatergic pathways (Fenselau *et al*, [2017](#embj2018100087-bib-0026){ref-type="ref"}). Undoubtedly, CRH (and likely glutamate) release at the median eminence is the dominant function for CRH neurons to mobilize glucocorticoids to set bodily (particularly muscular) "fight/flight" responses. Nevertheless, a key postulate of our present and earlier (Romanov *et al*, [2017a](#embj2018100087-bib-0073){ref-type="ref"}) studies is that molecularly heterogeneous CRH neurons shape more than a single output pathway, with glutamatergic CRH^+^ neurons integrating and propagating the most diverse hypothalamic network activity into a binary code. Once activated, ependymal cells convert synaptic inputs into a long‐lasting metabolic state change with CNTF released into the 3^rd^ ventricle. This is important since it not only links PVN output to distal midbrain effector systems (such as NE efferents) but also suggests that this event ensures context independence: NE activation occurs under the most diverse stress conditions (Arnsten, [2009](#embj2018100087-bib-0008){ref-type="ref"}). This understanding also mandated our approach to assess stress‐related behaviors. Irrespective of the threat, acute stress invariably triggers an initial freezing response before context‐dependent avoidance behavior manifests (Korte, [2001](#embj2018100087-bib-0045){ref-type="ref"}; Swiergiel *et al*, [2007](#embj2018100087-bib-0092){ref-type="ref"}, [2008](#embj2018100087-bib-0093){ref-type="ref"}; Egan *et al*, [2009](#embj2018100087-bib-0023){ref-type="ref"}). Therefore, we focused on this critical period of immobility with its duration interpreted as a behavioral correlate of the extent of NE afferent activation in the PFC. We show at successive levels of the PVN‐LC‐PFC circuit (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}A) that manipulation of CNTF release in ventricular ependyma, secretagogin‐dependent NE production in LC, or glutamate signaling in the PFC lengthens freezing behavior. Thus, we uncover a causal neural determinant that drives the initial behavioral stage of the stress response, which then can be followed by a refined repertoire of conscious and/or metabolic decisions to ensure adequate and proportionate response to a particular environmental stressor.

CRH^+^ parvocellular cells of the PVN innervate the median eminence to release their neuropeptide content into the portal circulation for stimulated ACTH release. Recently, we have demonstrated that both glutamatergic and GABAergic subtypes of CRH^+^ neurons exist in the mammalian hypothalamus (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}, [2017b](#embj2018100087-bib-0074){ref-type="ref"}). We have recently tied CRH^+^ neuroendocrine cells to the HPA axis as its first‐responder "*stress‐on*" components by identifying their use of *Scgn*, a parvocellular neuron‐specific Ca^2+^‐sensor protein, to facilitate fast vesicular neuropeptide secretion (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}, [2017a](#embj2018100087-bib-0073){ref-type="ref"}). However, the classical concept of CRH release leaves the fast neurotransmitter content (irrespective of that being glutamate or GABA) unaccounted for. Here, we combine viral circuit mapping, high‐resolution morphological analysis of GFP‐tagged synapses formed by CRH^+^ neurons, single‐cell RNA‐seq of their ependymal targets, and chemical probing to suggest the predominant use of glutamate for the focal stimulation of CNTF release. Our interpretation is supported by the lack of CRH receptors mRNAs (*Crhr1*/*Crhr2*) in ependymal cells together with frequent VGLUT2 and VGLUT1 co‐localization in CRH^+^/GFP^+^ presynapses. Thus, we have successfully exploited the power of "forward transcriptomics" (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}) to predict molecular circuit determinants, including the identity of the effector molecule released by ependymal cells in an activity‐dependent fashion.

Mono‐ or polysynaptic neurotransmission is the most precise form of intercellular communication in the brain. The "tripartite synapse doctrine" includes astroglial end‐feet (Araque *et al*, [1999](#embj2018100087-bib-0006){ref-type="ref"}) as well as efficient re‐uptake mechanisms to eliminate surplus neurotransmitters, thus spatially confining their action and limiting spillover (Huang & Bordey, [2004](#embj2018100087-bib-0038){ref-type="ref"}). In contrast, to modulate brain functions, the action of blood‐borne peripheral messengers, such as peptide hormones and lipids, is specified by their ability to cross the blood--brain barrier and the cell‐type specificity of their cognate receptors (Alpár & Harkany, [2013](#embj2018100087-bib-0004){ref-type="ref"}). An intermediary between these mechanisms is volume transmission, defined as a lack of specific and spatially demarcated conduits between the site of ligand production and receptor‐mediated signaling within a specific tissue (Fuxe *et al*, [2013](#embj2018100087-bib-0031){ref-type="ref"}). Purines and purine nucleotides (e.g., ATP), catecholamines, and hormones are commonly used for both short‐ and long‐range volume transmission (Fuxe *et al*, [1988](#embj2018100087-bib-0030){ref-type="ref"}; Roper, [2007](#embj2018100087-bib-0076){ref-type="ref"}; Housley *et al*, [2009](#embj2018100087-bib-0037){ref-type="ref"}). Here, we define a novel function for a developmentally regulated neurotrophin (Sendtner *et al*, [1994](#embj2018100087-bib-0083){ref-type="ref"}) by showing stress‐induced CNTF release into the cerebrospinal fluid in the adult brain. This finding is significant since it allows the conversion of fast synaptic excitation ("bouts of activity") into long‐lived neuromodulation through the use of the brain\'s aqueductal system. Our results also strengthen the recent concept that most signaling systems for axon growth and directional guidance including brain‐derived neurotrophic factor (BDNF)--tropomyosin receptor kinase B (TrkB; Song *et al*, [1997](#embj2018100087-bib-0518){ref-type="ref"}), Slit--Roundabout (Alpár *et al*, [2014](#embj2018100087-bib-0501){ref-type="ref"}; Guan *et al*, [2007](#embj2018100087-bib-0503){ref-type="ref"}), endocannabinoid (Berghuis *et al*, [2007](#embj2018100087-bib-0502){ref-type="ref"}), and semaphorin--plexin signaling (Orr *et al*, [2017](#embj2018100087-bib-0064){ref-type="ref"}) switch from their developmental roles to tune synaptic neurotransmission and plasticity, often via retrograde signaling, in the postnatal brain. Here, CNTF satisfies a role to enhance NE activity in the LC, alike BDNF released onto cortical interneurons (Inagaki *et al*, [2008](#embj2018100087-bib-0505){ref-type="ref"}; Magby *et al*, [2006](#embj2018100087-bib-0508){ref-type="ref"}), but does so through volume transmission in the liquor space. Then, CNTF action is specified by the expression of its cognate Trk receptor (CNTFRα) in NE neurons of the brainstem (Ip *et al*, [1993](#embj2018100087-bib-0039){ref-type="ref"}). It is noteworthy that Trk receptor activation assures fast onset (within 1--2 min) with signaling up to hours depending on the signal transduction pathway (Sermasi *et al*, [2000](#embj2018100087-bib-0084){ref-type="ref"}; Mizoguchi *et al*, [2002](#embj2018100087-bib-0057){ref-type="ref"}; Rosch *et al*, [2005](#embj2018100087-bib-0077){ref-type="ref"}). Thereby, Trk receptors might be best suited to produce activity patterns that match the species\' needs for survival and produce evolutionary advantage.

CNTF is only one neuromodulator whose mRNA is found in ependymal cells (Fig [1](#embj2018100087-fig-0001){ref-type="fig"}C). Single‐cell RNA‐seq also resolved gene expression for BDNF, *vgf*, which produces alternative peptide products for release in endocrine tissues (Ferri & Possenti, [1996](#embj2018100087-bib-0027){ref-type="ref"}), and neuropeptides, suggesting their combinatorial action if co‐released. Alternatively, mature peptides might be partitioned to spatially segregated subsets of ependymal cells entrained by distinct neuronal inputs for function determination, or their release depends on specific biophysical properties to gain specificity. Even if these neuroactive substances were ubiquitously co‐released, then the receptor repertoire of their cellular targets could diversify their action. Ultimately, ependymal cells could thus produce temporary neuropeptide constellations for volume transmission whose differential binding and output modulation in nearby midbrain and hindbrain structures could account for substantial functional heterogeneity and explain key features of neuropeptide contributions to anxiety and depression (Belzung *et al*, [2006](#embj2018100087-bib-0013){ref-type="ref"}; Barde *et al*, [2016](#embj2018100087-bib-0012){ref-type="ref"}).

NE neurons are commonly identified by their ubiquitous TH expression. Recently, functional evidence together with viral circuit tracing and optogenetic analysis demonstrates that a subset of NE neurons specifically innervates the PFC to drive emotional flexibility, while others project to the amygdala to modulate fear (Uematsu *et al*, [2017](#embj2018100087-bib-0097){ref-type="ref"}). Here, our data suggest that the co‐existence of CNTFRα, secretagogin, and TH is minimally sufficient to distinguish PFC‐projecting NE neurons even without making use of their deeper transcriptome. Molecular characteristics of NE neurons in humans suggest evolutionary conservation of this circuit, which is supported by clinicopathological data from stratified cohorts of humans with acute heart attack‐induced pain, which is considered as the strongest stressor known to humans. Notably, our animal models confirm that breaking hypothalamus‐LC‐mPFC signaling at the level of secretagogin in NE neurons renders animals insensitive to pain‐induced stress. Thus, our findings are not only significant in the context of psychiatric disorders (e.g., post‐traumatic stress disorder) but extend to a wider spectrum of states, including nosocomial interventions (e.g., patients who show oversensitivity to dental intervention‐induced pain; Klepac *et al*, [1980](#embj2018100087-bib-0042){ref-type="ref"}). Considering that the maintenance of heightened NE activity in the cerebral cortex characterizes the transition from acute to chronic stress (Arnsten, [2009](#embj2018100087-bib-0008){ref-type="ref"}), our findings might gain importance as a druggable cellular platform (e.g., CNTFRα inhibitors or modulators of Ca^2+^‐sensor proteins) to combat devastating human neuropsychiatric conditions (Bremner *et al*, [2008](#embj2018100087-bib-0014){ref-type="ref"}).

Materials and Methods {#embj2018100087-sec-0011}
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Reagents and tools table {#embj2018100087-sec-0012}
------------------------

Reagent/resourceSourceIdentifier**Antibodies**β‐ActinSigmaCat\#A1978CalbindinSynaptic SystemsCat\#2014104CNTFR&D SystemsCat\#AF‐557‐NACNTF receptorR&D SystemsCat\#AF‐559‐NACRHSanta CruzCat\#SC‐1759EnkephalinImmunostarCat\#20065Erk1/2Cell SignalingCat\#9107Phosphorylated Erk1/2Cell SignalingCat\#9101GFAPDAKOCat\#Z0334GRIA1AlomoneAGP‐009Neuropeptide YImmunostarCat\#22940NestinMilliporeMAB353SecretagoginGift from L. Wagner(rabbit)SecretagoginR&D SystemsCat\#AF4878SynaptophysinSynaptic SystemsCat\#101‐002SMI301BioLegendCat\#801702Tyrosine hydroxylase (TH)Merck/MilliporeCat\#AB152TH phosphorylated at Ser^31^SigmaCat\#SAB4300674TH phosphorylated at Ser^40^SigmaCat\#T9573VGLUT1Synaptic SystemsCat\#135‐202VGLUT2Synaptic SystemsCat\#135‐404Biotinylated Donkey Anti‐Rabbit IgGJackson ImmunoR.Cat\#711‐065‐152Cy2‐conjugated Donkey Anti‐Goat IgGJackson ImmunoR.Cat\#705‐225‐003Cy2‐conjugated Donkey Anti‐Rabbit IgGJackson ImmunoR.Cat\#711‐225‐152Cy3‐conjugated Donkey Anti‐Goat IgGJackson ImmunoR.Cat\#705‐165‐003Cy3‐conjugated Donkey Anti‐Rabbit IgGJackson ImmunoR.Cat\#711‐165‐152Cy3‐conjugated Donkey Anti‐Guinea Pig IgGJackson ImmunoR.Cat\#706‐165‐148Cy5‐conjugated Donkey Anti‐Rabbit IgGJackson ImmunoR.Cat\#711‐175‐152Cy2‐StreptavidinJackson ImmunoR.Cat\#016‐220‐084Normal Goat IgGSanta CruzCat\#sc‐2028Dynabeads Protein GInvitrogenCat\#10004DDonkey Anti‐Rabbit HRPJackson ImmunoR.Cat\#711‐035‐152Donkey Anti‐Mouse HRPJackson ImmunoR.Cat\#715‐035‐151Donkey Anti‐Goat HRPJackson ImmunoR.Cat\#705‐035‐147**Chemicals, peptides, and recombinant proteins**L‐norepinephrineSigmaCat\#74480Recombinant Ciliary Neurotrophic FactorSigmaCat\#C3710Biotinylated Dextran Amine (BDA, 10,000 MW)InvitrogenCat\#D1956Biotinylated Dextran Amine (BDA, 3,000 MW)Molecular ProbesCat\#D7135Clarity Western ECL SubstrateBIO‐RADCat\#170‐5060Vectastain ABC KitVector LabsCat\#PK‐6101DAB Peroxidase Substrate KitVector LabsCat\#SK‐4100jetPRIMEPolyplusCat\#114‐15TSA Plus Fluorescein System KitPerkinElmerNEL741001KTKetamine (Calypsol)RichterCat\#A6A066Xylazine (Nerfasin)Le Vet PharmaCat\#15H044Isoflurane (Forane^®^)AbbVie GmbHCat\#B506Hoechst 33,342Thermo FisherCat\#H1399**Critical commercial assays**CNTF Rat ELISA kitThermo Fisher Sci.Cat\#ERCNTF**Deposited data**Single‐cell RNA‐seq of mouse hypothalamus cells from control and acute formalin‐stressed animalsNCBI Gene Expression OmnibusGSE74672**Experimental models: cell lines**INS‐1EGift from P. MaechlerExperimental models: organisms/strains*Crh*‐*Ires*‐Cre::egfp mouseGift from J.S. BainsCat\#012704*cfos*‐Cre^ERT2^ mouseJAX LabsCat\#021882*ROSA26‐stop‐ZsGreen1* ^*f*/*f*^ mouse (*Ai6*)JAX LabsCat\#007906*Scgn* ^*−*/−^ miceMMRRC for authorsMalenczyk *et al* ([2017](#embj2018100087-bib-0509){ref-type="ref"})*Cntf* ^*−*/*−*^ *mice*A. GiordanoMasu *et al* ([1993](#embj2018100087-bib-0510){ref-type="ref"})*Scgn‐*Cre mouseG. SzabóDeveloped for this studyAAV8‐EF1a‐double floxed‐hChR2(H134R)‐mCherry‐WPRE‐HGHpAAddgene Viral ServiceCat\#20297AAV8‐hSyn‐DIO‐hM3D(Gq)‐mCherryAddgene Viral ServiceCat\#44361AAV8‐hSyn‐DIO‐hM4D(Gi)‐mCherryAddgene Viral ServiceCat\#44362AAV8‐hSyn‐DIO‐hM3D(Gq)‐mCherryAddgene Viral ServiceCat\#44361pAAV‐hSyn‐DIO‐mCherryAddgene Viral ServiceCat\#50459AAV‐hSyn1‐GCaMP6f‐P2A‐nls‐dTomatoAddgene Viral ServiceCat\#51085**Sequence‐based reagents**Primers for CNTFIDTRef\#72797892‐3Control siRNASanta CruzCat\#sc‐37007SCGN siRNASanta CruzCat\#sc‐153255Accell SMARTpool CNTF siRNAGE DharmaconCat\#A‐091086Accell SMARTpool SCGN siRNAGE DharmaconCat\#A‐092169Accell SMARTpool non‐targeting siRNAGE DharmaconCat\#D‐001950‐01**Software and algorithms**Clampfit 10.0Molecular DevicesVer. pCLAMP‐10MiniAnalysisSynaptosoft"MiniAnalysis"SigmaPlotSystatStatistical Package for the Social Sciences 17.0SPSS IncImage Lab 5.0BIO‐RAD
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### Animals {#embj2018100087-sec-0014}

*Scgn* ^−/−^ mice were custom‐generated at MMRRC (Mouse Biology Program, University of California) using the "two‐in‐one" targeting strategy (Skarnes *et al*, [2011](#embj2018100087-bib-0517){ref-type="ref"}), which generates full knock‐outs by expressing a termination signal after exon 3 of the secretagogin gene. The ensuing truncated protein terminates before the first EF‐hand domain, excluding Ca^2+^‐binding activity. *Crh‐Ires*‐Cre (from J.S. Bains, University of Calgary, Canada) were crossed with B6.Cg‐*Gt(ROSA)26Sor* ^*tm6(CAG‐ZsGreen1)Hze*^/J mice (*Ai6*; JAX stock \#012704 and \#007906) to visualize periventricular innervation by CRH neurons (Romanov *et al*, [2017a](#embj2018100087-bib-0073){ref-type="ref"},[b](#embj2018100087-bib-0074){ref-type="ref"}). *Scgn*‐Cre mice were developed using the BAC technology (Calvigioni *et al*, [2017](#embj2018100087-bib-0015){ref-type="ref"}; Z.M., F.E., and G.S., Institute of Experimental Medicine, Hungarian Academy of Sciences). When using Wistar rats, experiments were performed at 12 weeks of age. Animals were kept under standard housing condition (including a 12‐h/12‐h light/dark cycle) with food and water available *ad libitum*. Experimental procedures, including CSF sampling from the 4^th^ ventricle and transcardial perfusion, were approved by the ethical review boards of the Semmelweis University (PE/EA/1234‐3/2017, Hungary) and the Medical University of Vienna (BMWFW‐66.009/0277‐WF/V/3b/2017, Tierversuchgesetz 2012, BGBI, Nr. 114/2012), including the size estimate of each experimental cohort. All procedures conformed to the European Convention for the Protection of Vertebrate Animals used for experimental and other scientific purposes (86/609/EEC). Wherever possible, animals of the same genotype were randomly assigned to experimental manipulations (control vs. various treatments) to reduce procedural bias. During surgery or transcardial perfusion, animals were anesthetized intramuscularly (i.m.) or intraperitoneally (i.p.) with a mixture of ketamine (50 mg/kg b.wt.) and xylazine (4 mg/kg b.wt.) or by inhalation of isoflurane (at 5% with 1 l/min flow rate of tubed air).

### Locus coeruleus explants {#embj2018100087-sec-0015}

Postnatal day (P) 5 rat brains (*n *=* *6) were vibratome‐sectioned coronally at 300 μm thickness in ice‐cold DMEM containing penicillin (100 U/ml) and streptomycin (100 μg/ml, both from Invitrogen). *Ex vivo* slices containing the locus coeruleus (LC) were mounted on Millicell‐CM culture inserts (0.4 μm pore size; Millipore) and equilibrated in Neurobasal Medium containing 2 mM GlutaMAX and 10% fetal bovine serum (FBS) for 2 h. Subsequently, the medium was replaced with Neurobasal Medium, GlutaMAX (2 mM), and B27 supplement (2%) for 24 h when recombinant CNTF (100 ng in 2.5 μl medium; Sigma) was applied directly onto each brain slice for 20 min. Tissues were then collected, washed, homogenized in TNE lysis buffer, and processed for Western blotting.

### Cell lines {#embj2018100087-sec-0016}

Rat‐derived INS‐1E insulinoma cells (gift from P. Maechler; Merglen *et al*, [2004](#embj2018100087-bib-0055){ref-type="ref"}) were maintained in RPMI‐1640 containing HEPES (10 mM), fetal bovine serum (FBS; 5%), Na‐pyruvate (1 mM), GlutaMAX (2 mM), β‐mercaptoethanol (50 μM), penicillin (100 U/ml), and streptomycin (100 μg/ml; all from Invitrogen). Cells were enzymatically dissociated and plated at a density of 500,000 cells/well on poly‐D‐lysine‐coated coverslips in 6‐well plates for Western blotting or qPCR.

### Human samples {#embj2018100087-sec-0017}

For Western analysis, micropunched LC samples were obtained from subjects deceased due to acute heart failure or suicide at the Human Brain Tissue Bank and Laboratory, Semmelweis University, Hungary ([Appendix Table S1](#embj2018100087-sup-0001){ref-type="supplementary-material"}). Tissues were obtained and used in compliance with the Declaration of Helsinki and following relevant institutional guidelines \[Regional and Institutional Committee of Science and Research Ethics of Semmelweis University (TUKEB 84/2014)\]. All patient material was coded to ensure anonymity throughout tissue processing.

### Formalin stress {#embj2018100087-sec-0018}

Twelve‐week‐old animals were used in all experiments. Rats (*n *=* *8) received an injection of 4% paraformaldehyde (PFA; in 50 μl physiological saline) into their right hind paw and subsequently returned to their home cages. After either 20 or 120 min, the animals (*n *=* *4/time point) were decapitated and their brains dissected out. The medullary--pontine brainstem and medial prefrontal cortex were isolated and subjected to protein analysis by Western blotting. Control animals (*n *=* *4) were removed from their home cages only for decapitation and tissue sampling. *Scgn* ^−/−^ mice and their wild‐type littermates (*n *=* *3 each) were subjected to an identical treatment but with subsequent tissue collection restricted to 20 min post‐induction. Control mice of both genotypes were left in their home cages until decapitation to minimize bias by acute handling and immobilization. To discriminate the pool of stress‐activated periventricular ependymal cells, *cfos*‐Cre^ERT2^::*ROSA26‐stop‐ZsGreen1* ^*f*/*f*^ "TRAP mice" were used (JAX stock \#021882 and \#007906) as per published protocols (Guenthner *et al*, [2013](#embj2018100087-bib-0034){ref-type="ref"}). In brief, 24 h after a single‐bolus tamoxifen injection (150 mg/kg), 4% PFA (in 50 μl physiological saline) was injected as above to induce stress acutely. After a lag‐time of 72 h to allow for ZsGreen expression in "stress‐responder" cells, animals were transcardially perfused with a fixative containing 4% PFA in 0.1 M phosphate buffer (PB, pH 7.4) for quantitative histochemical analysis (see below).

### Virus microinjections *in vivo* {#embj2018100087-sec-0019}

Stereotaxic injections were performed as described (Romanov *et al*, [2017a](#embj2018100087-bib-0073){ref-type="ref"},[b](#embj2018100087-bib-0074){ref-type="ref"}). Briefly, mice were anesthetized with isoflurane (5%, 1 l/min flow rate) and placed in a stereotaxic frame (Narishige). A Quintessential Stereotaxic Injector (Stoelting) was used to inject virus particles at a speed of 50--100 nl/min. The pipette (Drummond) was slowly withdrawn 5 min after injection. Fourteen to twenty‐five days after viral injections, animals were used for (i) mapping local and long‐range projections, (ii) slice electrophysiology, (iii) Ca^2+^ imaging, and (iv) behavioral tests. AAV8‐EF1a‐double floxed‐hChR2(H134R)‐mCherry‐WPRE‐HGHpA (Addgene Viral Service, \#20297) was unilaterally injected on LC (100 nl; coordinates from bregma: AP: −5.4 mm, DV: −3.7 mm, ML: ±0.9 mm) of *Scgn*‐Cre mice. For behavioral testing, AAV8‐hSyn‐DIO‐hM3D(Gq)‐mCherry (Addgene, \#44361) or AAV8‐hSyn‐DIO‐hM4D(Gi)‐mCherry (Addgene, \#44362) was bilaterally injected in LC (125 nl/side; coordinates relative to bregma: AP: −5.4 mm, DV: −3.7 mm, ML: ±0.9 mm) of *Scgn*‐Cre mice. Likewise, AAV8‐hSyn‐DIO‐hM3D(Gq)‐mCherry or pAAV‐hSyn‐DIO‐mCherry (Addgene, \#50459) was unilaterally injected into the PVN (40 and 25 nl, respectively, coordinates relative to bregma: AP: −0.7 mm, DV: −4.8 mm, ML: ±0.2 mm) for *ex vivo* electrophysiology and projection mapping. For Ca^2+^ imaging, LC neurons projecting to the mPFC were retrogradely loaded by using AAV‐hSyn1‐GCaMP6f‐P2A‐nls‐dTomato (Addgene, \#51085, 300 nl, coordinates relative to bregma: AP: +1.8 mm, DV: −2.6 mm, ML: ±0.25 mm).

### Anterograde tracing {#embj2018100087-sec-0020}

Rats (*n *=* *4 at 12 weeks of age) received an injection of biotinylated dextran amine (BDA, 10,000 Da, 10%, 0.2 μl injection volume; Molecular Probes) into the locus coeruleus (LC) under deep anesthesia (coordinates: 1.5 mm lateral, +9.7 mm caudal to bregma, and −6.0 mm ventral from the dural surface) with their heads fixed in a stereotaxic frame. Seven days after surgery, the animals were transcardially perfused and their brains processed for immunohistochemistry.

### Retrograde tracing {#embj2018100087-sec-0021}

Rats (*n *=* *4 at 12 weeks of age) were deeply anesthetized and their head fixed in a stereotaxic frame and biotinylated dextran amine (3,000 MW, 2 μl, 10%; Molecular Probes) infused in the PFC unilaterally at the coordinates: AP: 0.5 mm, DV: 2.5 mm, and ML: −4.5 mm. After a 7‐day survival period, animals were transcardially perfused and their brains processed for immunohistochemistry.

### Ventricular administration of CNTF via icv cannula {#embj2018100087-sec-0022}

For the experiments, rats (*n *=* *14 at 12 weeks of age) and transgenic mice \[*Cntf* ^−/−^ (*n *=* *10), *Scgn* ^−/−^ (*n *=* *10), and corresponding littermates (*n *=* *10 each)\] were used. To administer CNTF in awake animals, an icv cannula (PlasticsOne) was introduced into the lateral ventricle and fixed to the skull by using Zn~3~(PO~4~)~2~ cement (Adhesor; Pentron). A guide cannula was placed into the brains of both rats (4 mm long, i.d. × o.d. = 0.39 × 0.71 mm, at AP: −0.9 mm, ML: +1.4 mm, DV: −4.0 mm) and mice (3 mm long, i.d. × o.d. = 0.39 × 0.71 mm, t AP: −0.2 mm, ML: +1.0 mm, DV: −3.0 mm) under deep anesthesia. After 7 days, rats received CNTF (*n *=* *7, 4 μl, 6 ng/μl) or artificial cerebrospinal fluid (*n *=* *7, aCSF, 4 μl) through an internal cannula (4.5 mm long, i.d. × o.d. = 0.18 × 0.36 mm). In mice (*n *=* *5/genotype for CNTF or aCSF), drug infusion (3 μl) was made by using internal cannulas with specifications as follows: 3 mm long, i.d. × o.d. = 0.39 × 0.71 mm; and 3.5 mm long, i.d. × o.d. = 0.39 × 0.71 mm. Sixty minutes after CNTF or vehicle infusion, animals were subjected to an open‐field test. Subsequently, animals were decapitated and their medullopontine brainstem and mPFC removed and processed for protein (Western blotting) and catecholamine (HPLC) analysis, respectively.

### Sampling of cerebrospinal fluid (CSF) {#embj2018100087-sec-0023}

Formalin‐stressed (*n *=* *4) and control (*n *=* *4) rats (12 weeks of age) were deeply anesthetized and their head fixed into a stereotaxic frame with maximal anteflexion. To approach the 4^th^ ventricle, the skin was incised, nuchal muscles pulled to the sides, and the bony tissue below the cerebellum removed using a surgical drill. The lamina epithelialis was identified as being immediately caudal to the cerebellum and pierced with a 26‐G syringe. Subsequently, 15 μl CSF was removed from the 4^th^ ventricle using a standard 20‐μl laboratory pipette (Eppendorf; Cottrell *et al*, [2004](#embj2018100087-bib-0019){ref-type="ref"}).

### Transcardial perfusion {#embj2018100087-sec-0024}

Animals were routinely perfusion‐fixed with 4% PFA in 0.1M PB (pH 7.4) under deep anesthesia as described (Alpár *et al*, [2014](#embj2018100087-bib-0501){ref-type="ref"}; Lendvai *et al*, [2013](#embj2018100087-bib-0507){ref-type="ref"}; Mulder *et al*, [2009](#embj2018100087-bib-0060){ref-type="ref"}; Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}).

### Immunohistochemistry, microscopy, and imaging {#embj2018100087-sec-0025}

Free‐floating sections (30 μm) were rinsed in PB (pH 7.4) and pre‐treated with 0.3% Triton X‐100 (in PB) at 22--24°C for 1 h to enhance the penetration of antibodies (for references, see Alpár *et al*, [2004](#embj2018100087-bib-0500){ref-type="ref"}, [2014](#embj2018100087-bib-0501){ref-type="ref"}; Lendvai *et al*, [2013](#embj2018100087-bib-0507){ref-type="ref"}; Mulder *et al*, [2009](#embj2018100087-bib-0060){ref-type="ref"}; Ong *et al*, [2014](#embj2018100087-bib-0063){ref-type="ref"}; Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}; Severi *et al*, [2012](#embj2018100087-bib-0085){ref-type="ref"}; Severi *et al*, [2013](#embj2018100087-bib-0516){ref-type="ref"}). Non‐specific immunoreactivity was suppressed by incubating our specimens in a cocktail of 5% normal donkey serum (NDS; Jackson ImmunoResearch), 2% bovine serum albumin (BSA; Sigma), and 0.3% Triton X‐100 (Sigma) in PB at 22--24°C for 1 h. Sections were then exposed (16--72 h at 4°C) to select combinations of primary antibodies (Tools and Reagents Table) diluted in PB to which 0.1% NDS and 0.3% Triton X‐100 had been added. We used tyramide signal amplification (PerkinElmer) to detect CNTF receptor immunoreactivity. After extensive rinsing in PB, sections were processed by using chromogenic or immunofluorescence detection methods as described previously (Lendvai *et al*, [2013](#embj2018100087-bib-0507){ref-type="ref"}). In single labeling experiments using chromogenic amplification, biotinylated anti‐rabbit IgG raised in donkey (1:1,000; Jackson ImmunoResearch, at 22--24°C for 2 h) was used as secondary antibody followed by exposure to pre‐formed avidin--biotin complexes also incorporating horseradish peroxidase at 22--24°C for 1 h. Immunosignals were visualized by 3,3′‐diaminobenzidine (Sigma, 0.025%) as chromogen intensified with Ni‐ammonium sulfate (Merck, 0.05%) in the presence of 0.001% H~2~O~2~ as substrate (dissolved in 0.05 M Tris buffer, pH 8.0). In multiple immunofluorescence labeling experiments, immunoreactivities were revealed by carbocyanine (Cy) 2‐, 3‐, or 5‐tagged secondary antibodies raised in donkey \[1:200 (Jackson ImmunoResearch), at 22--24°C for 2 h\]. In human samples, lipofuscin autofluorescence was quenched by applying Sudan Black B (1%, dissolved in 70% ethanol; Schnell *et al*, [1999](#embj2018100087-bib-0515){ref-type="ref"}). Glass‐mounted sections were coverslipped with glycerol/gelatin (GG‐1; Sigma). Results of chromogenic histochemistry were captured on a NIKON Eclipse Microscope. The sections processed for multiple immunofluorescence histochemistry were inspected and images acquired on a LSM780 confocal laser‐scanning microscope (Zeiss) with optical zoom ranging from 1× to 3× at 63× primary magnification (Plan‐Apochromat 63×/1.40), and pinhole settings limiting signal detection to 0.5--0.7 μm "optical thickness". Emission spectra for each dye were limited as follows: Cy2 (505--530 nm), Cy3 (560--610 nm), and Cy5 (650--720 nm). VGLUT2^+^ and GRIA1^+^ profiles were 3D‐reconstructed using the cell surface reconstruction tool of Imaris x64 (version 9.0.2, BitPlane). Multi‐panel figures were assembled in CorelDraw X7 (Corel Corp.).

### Electron microscopy {#embj2018100087-sec-0026}

Animals were perfusion‐fixed with 4% PFA and 0.1% glutaraldehyde in 0.1 M PB and their brains dissected out and cut on a vibratome (Leica V1200S). Sections were osmificated, dehydrated, and embedded in Durcupan (Fluka, ACM). Sixty‐nanometer‐thick ultrathin sections were prepared on an Ultracut UCT ultramicrotome (Leica) and analyzed on a Tecnai 10 electron microscope.

### Quantitative image analysis {#embj2018100087-sec-0027}

Images from serial sections (*n *=* *4 per animal and condition) were captured using a Zeiss LSM880 confocal laser‐scanning microscope. CRH^+^ boutons or GFAP^+^/*ZsGreen1* ^+^ cells were identified offline by an experimenter blinded to the case conditions and their density calculated in demarcated regions of interest (ROIs) using the ZEN software (Zeiss). In all cases, histochemical specimens were also pre‐coded to minimize bias. ROIs were defined as a 15‐μm‐wide periventricular rim around the 3^rd^ ventricle. Thereafter, the length of the ventricular surface was measured (in μm) with GFAP^+^/*ZsGreen1* ^+^ cell numbers or CRH^+^ bouton numbers normalized and expressed per mm or per 100 μm^2^, respectively. CNTFR^+^ boutons were counted along the perimeter of BDA^+^ (retrogradely labeled)/TH^+^ and BDA^−^/TH^+^ LC neurons. The perimeter of neurons was measured using ZEN2010 (Zeiss), expressed as μm, and used to normalize the density of CNTFR^+^ profiles.

### Immunoprecipitation {#embj2018100087-sec-0028}

Brainstems were isolated from 12‐week‐old rats (*n *=* *3) and collected in lysis buffer containing 50 mM NaCl, 20 mM HEPES, 10 μM CaCl~2~, 0.2% Triton X‐100, and a cocktail of protease inhibitors (Roche; pH was adjusted to 7.4). Tissues were homogenized by sonication and centrifuged at 18,000 *g* for 30 min. Only supernatants were used in subsequent experiments. Samples (50 μl) were incubated with rabbit anti‐secretagogin primary antibody (1:2,000; provided by L. Wagner) overnight at 4°C. An aliquot of each sample was probed in parallel with rabbit IgG (2 μg/50 μl; Santa Cruz) to control for non‐specific binding. Subsequently, samples were incubated with protein G Dynabeads (Novex; Life Technologies) for 90 min. After repeated rinses, Dynabeads were collected and bound proteins eluted with Laemmli buffer and separated on 10% resolving gels under denaturing conditions (SDS--PAGE). LC micropunches from human subjects deceased due to acute heart failure were processed according to a protocol identical to that used for rat samples.

### Western blotting {#embj2018100087-sec-0029}

Protein samples were prepared from both rat (*n *=* *8) and mouse (*n *=* *12) brain stems by natively cutting them at 300 μm thickness on a Leica 1850 cryostat. Consecutive sections (six in rats, four in mice) containing the locus coeruleus (LC) were collected to form a sample. Medial prefrontal cortices were excised on a pre‐chilled surface under a stereomicroscope. Tissues were sonicated in TNE buffer containing 0.5% Triton X‐100 (Sigma), 1% octyl‐β‐D‐glucopyranoside (Calbiochem), 5 mM NaF, 100 μM Na~3~VO~4~, and a mixture of protease inhibitors (Complete™; Roche). Cellular debris and nuclei were pelleted by centrifugation (800 *g*, 4°C, 10 min). Protein concentrations were determined by Bradford\'s colorimetric method (Bradford, 1976). Samples were diluted to a final protein concentration of 2 μg/μl, denatured in 5× Laemmli buffer, and analyzed by SDS--PAGE on 8 or 10% resolving gels. After transfer onto Immobilon‐FL PVDF membranes (Millipore), membrane‐bound proteins were blocked (1.5 h) with 3% BSA and 0.5% Tween‐20 in Tris‐buffered saline and subsequently exposed to primary antibodies (Tools and Reagents Table) at 4°C overnight. Combinations of HRP‐conjugated secondary antibodies (from goat, rabbit, or mouse hosts, Jackson ImmunoResearch, 1:10,000, 2 h) were used for signal amplification. Image acquisition and analysis were performed on a Bio‐Rad XRS^+^ imaging platform equipped with Image Lab 3.01 software (Bio‐Rad Laboratories). β‐Actin (1:10,000; Sigma) was used as loading control.

### Synaptosomal proteins {#embj2018100087-sec-0030}

Rats (*n *=* *2, 12 weeks of age) were perfused with ice‐cold saline with their brains rapidly dissected out. The medial prefrontal cortex was excised and homogenized in 0.32 M sucrose‐containing HEPES buffer (in mM: 145 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, 5 glucose, and 5 HEPES at pH 7.4). After centrifugation, the supernatant was repeatedly cleared (by centrifugation at 15,000 *g* in 1.3 M sucrose‐containing HEPES buffer). The resultant pellet, enriched in synaptic proteins (Ramos‐Ortolaza *et al*, [2010](#embj2018100087-bib-0512){ref-type="ref"}), was used to probe the presynaptic enrichment of secretagogin.

### Quantitative PCR {#embj2018100087-sec-0031}

RNA was extracted using the RNeasy mini kit (Qiagen) with a DNase I step performed to eliminate traces of genomic DNA, and reverse‐transcribed using a high‐capacity cDNA reverse transcription kit (Applied Biosystems). Reactions were performed after an initial denaturation step at 95°C for 2 min followed by 40 cycles of 95°C for 1 min denaturation, annealing and extension at 60°C (1 min each), and a dissociation stage at 72°C (2 min) on a CFX 96 apparatus (Bio‐Rad). Primer pairs amplified short fragments of the *Cntf* gene (*forward:* 5′‐ATGGCTTTCGCAGAGCAAAC‐3′, *reverse:* 5′‐CAACGATCAGTGCTTGCCAC‐3′). Samples without reverse transcriptase served as negative controls. In select experiments, amplicons were resolved on 1% agarose gels ([Appendix Fig S1C](#embj2018100087-sup-0001){ref-type="supplementary-material"}).

### RNAi‐mediated gene silencing *in vitro* {#embj2018100087-sec-0032}

Knock‐down of *Scgn* mRNA expression in INS‐1E cells was through the application of *Scgn* siRNA (Santa Cruz, 250 pmol/500 μl, diluted and transfection carried out using JETPRIME reagents) for 48 h. To induce tyrosine hydroxylase phosphorylation, recombinant CNTF was added (40 ng/μl; Sigma) for 48 h. INS‐1E cells were lysed and processed for Western blotting.

### RNAi‐mediated gene silencing *in vivo* {#embj2018100087-sec-0033}

Male rats (12 weeks of age) received icv injections of either SMARTpool Accell *Cntf* siRNA (*n *=* *8; 4 μl volume, 1 nmol siRNA in total) or non‐targeting siRNA (*n *=* *8) as described previously (Romanov *et al*, [2015](#embj2018100087-bib-0072){ref-type="ref"}). After 4 days, rats (*n *=* *4) were subjected to formalin stress (4% PFA, 50 μl injection volume) or were left undisturbed in their home cages (*n *=* *4). After 60 min of PFA administration, animals were decapitated and their brains removed with the medullary--pontine brainstem and mPFC isolated and subjected to protein analysis by Western blotting. The remaining mPFC samples were subjected to HPLC analysis.

In a parallel series of experiments, the LC of male mice (12 weeks of age) was targeted stereotaxically by either SMARTpool Accell Scgn siRNA (*n *=* *3; 4 μl volume, 1 nmol siRNA in total) or non‐targeting siRNA (*n *=* *3). After 3 days, mice were subjected to formalin stress, by decapitation after 60 min. The medullary--pontine brainstem and bilateral mPFCs were used for Western blotting.

### High‐performance liquid chromatography {#embj2018100087-sec-0034}

*Scgn* ^−/−^ and wild‐type littermates (*n *=* *12 in total, all 10--12 weeks old) were sacrificed and their brains extracted and frozen on dry ice within 30 s. The medial prefrontal and parietal cortices (the latter equivalent to the S1 somatosensory area) were dissected from frozen coronal slices on a cold plate (at constant −10°C). Samples were ultrasonicated in 25 volumes of perchloric acid, Na‐bisulfite, and 3,4‐dihydroxybenzylamine as internal standard (final concentration 0.1 M, 0.4 mM, and 5 μg/l, respectively) and centrifuged at 16,100 *g* for 10 min. For the determination of tissue levels of norepinephrine (NE), dopamine (DA), and 3,4‐dihydroxyphenylacetic acid (DOPAC), supernatants were extracted with aluminum oxide and injected into a HPLC system with electrochemical detection as described (Pifl *et al*, [1991](#embj2018100087-bib-0511){ref-type="ref"}) with minor modifications (LiChroCART^®^ 250‐4, RP18μ, 5‐μm column, HP Programmable Electrochemical Detector 1049A, and a mobile phase with 9% methanol).

### Single‐cell RNA‐seq {#embj2018100087-sec-0035}

C57Bl6/N juvenile mice (P14--28) of both sexes in control were used for single‐cell collection as described (Romanov *et al*, [2017a](#embj2018100087-bib-0073){ref-type="ref"},[b](#embj2018100087-bib-0074){ref-type="ref"}). The processing of cells from male and female animals was random to minimize methodological bias. Mice were deeply anesthetized (5% isoflurane) and transcardially perfused with 40 ml ice‐cold pre‐oxygenated (95% O~2~/5% CO~2~) cutting solution containing (in mM) 90 NaCl, 26 NaHCO~3~, 2.5 KCl, 1.2 NaH~2~PO~4~, 10 HEPES‐NaOH, 5 Na‐ascorbate, 5 Na‐pyruvate, 0.5 CaCl~2~, 8 MgSO~4~, and 20 glucose. A central column of the mouse hypothalamus spanning the posterior preoptic area to the arcuate nucleus along its rostrocaudal axis, paraventricular nucleus (dorsally), and the ventrolateral hypothalamic area (laterally) was microdissected from serial 300‐μm‐thick coronal slices under microscopy guidance and then dissociated using the Papain Dissociation System (Worthington). Thus, isolated single cells included those that line the anterior extent of the 3^rd^ ventricle. Cells were concentrated by centrifugation to a density of 600--1,000 cells/μl. After mixing C1 suspension reagent (4 μl; Fluidigm) with the cell suspension (7 μl), this mixture was loaded into a C1‐AutoPrep IFC microfluidic chip designed for cells 10--17 μm in diameter (Fluidigm) and processed on a Fluidigm C1 instrument using the mRNA Seq: Cell Load (1,772×/1,773×) script (30 min at 4°C). The microfluidic plate was then transferred to an automated microscope (Nikon TE2000E) to acquire a bright‐field image of each capture site at 20× magnification using μManager (<https://micro-manager.org/>) in \< 15 min. Quality control for exclusion of debris or doublets was performed after each capture experiment. Following lysis, cDNA synthesis, amplification, and tagmentation, high‐throughput RNA sequencing was performed on an Illumina HiSeq 2000 sequencer (Islam *et al*, [2014](#embj2018100087-bib-0506){ref-type="ref"}). Next, the dataset was processed with the BackSpinV2 algorithm (Romanov *et al*, [2017a](#embj2018100087-bib-0073){ref-type="ref"},[b](#embj2018100087-bib-0074){ref-type="ref"}) and first grouped for main cell lineages. Ependymal cells were separated using genes associated with motile cilia, such as the *Enkur* and *Foxj1* gene pair (Romanov *et al*, [2017a](#embj2018100087-bib-0073){ref-type="ref"},[b](#embj2018100087-bib-0074){ref-type="ref"}; Roy, [2009](#embj2018100087-bib-0514){ref-type="ref"}; Zeisel *et al*, [2015](#embj2018100087-bib-0520){ref-type="ref"}). Here, we focused on neurotrophins, ionotropic and metabotropic receptors for glutamate and GABA, and neuropeptide receptors given that "*stress‐on*" CRH neurons in the paraventricular nucleus always contain a fast neurotransmitter in conjunction with CRH (Romanov *et al*, [2017a](#embj2018100087-bib-0073){ref-type="ref"},[b](#embj2018100087-bib-0074){ref-type="ref"}). Data were then rendered as heatmaps (GenePattern) for improved visual clarity.

### Neurological assessment {#embj2018100087-sec-0036}

Behavioral tests were conducted by the same experimenter---who was blinded to mouse phenotypes---in an isolated room and at the same time of day throughout. Three‐ to six‐week‐old mice \[*n *=* *9 (wild‐type) and *n *=* *13 *Scgn* ^−/−^\] were used. The animals were housed in groups of 3--5 per cage in standard macrolon cages under a 12‐h/12‐h light/dark schedule (lights on at 08:00) in controlled environmental conditions of humidity (50--65%) and temperature (22 ± 2°C) with food and water available *ad libitum*. All experimental procedures were approved by the local ethical committee of the Medical University of Vienna (BMWFW‐66.009/0277‐WF/V/3b/2017) and also met European legislative requirements. A modified SHIRPA protocol (Rogers *et al*, [2001](#embj2018100087-bib-0513){ref-type="ref"}) was used as comprehensive phenotyping tool. Herein, data on provoked sensory performance were presented as measures of stress responsiveness. First, mice were transferred to an arena (56 × 34 cm) for observation of sensory functions, including their pinna reflex response/refraction score (while the mouse being gently restrained, each auditory meatus was lightly touched with either ear retraction or head movement recorded at a scale of "0" = no response, "1" = active retraction, moderately brisk flick, "2" = hyperactive, repetitive flick). Foot withdrawal was assayed after lifting the mice by their tail and applying gentle lateral compression of the middle digit of their hind paw using a fine forceps (scoring: "0" = no response, "1" = slight withdrawal, "2" = moderate withdrawal, "3" = rapid withdrawal, "4" = rapid, brisk withdrawal with extension/flexion). Provoked biting was scored by approaching each gently immobilized mouse from the frontal direction with a cotton tab ("0" = present, "1" = absent, "2" = active exploration and embracing instead of defense). Subsequently, behavioral scores were ranked and processed statistically. Another cohort of mice (*n *=* *6/6 *Scgn* ^−/−^/wild‐type littermates, all 12--16 weeks old) were placed into a programmable foot‐shock chamber to habituate for 10 min each. The subsequent day, *n *=* *3 from both genotypes received a series of five foot‐shocks (0.8 mA) each during a period of 10.5 min with random intervals ranging from 90 to 120 s. Control animals (*n *=* *3 each) spent equivalent periods in the chamber without any manipulation. We used EthoVision (Noldus) to analyze the following parameters: (i) average latency to first movement after foot‐shock (only for mice from shock‐exposed groups; data represent average latency/mouse), (ii) total distance covered, and (iii) time spent at center ("cumulative duration") during 10.5 min.

The von Frey test, a mechanical non‐invasive nociceptive assay, was used to evaluate sensory threshold in *Scgn* ^−/−^ and in wild‐type littermates. Animals were placed on a metal frame, and their left hind paw was pressed from below with a series of Nylon rods (Touch Test Sensory Evaluator, EXACTA, North Coast Medical) corresponding to increasing applied weight. The sensory threshold of the animal was identified as the first rod which evoked withdrawal of the extremity.

### Open‐field and elevated plus maze tests {#embj2018100087-sec-0037}

To determine the acute effect of icv‐infused CNTF on open‐field behaviors, animals were transferred to a rectangular arena of either 90 × 90 cm for rats or 40 × 40 cm for mice 60 min after CNTF application through a guide cannula. Spontaneous locomotor behaviors were recorded with an overhead camera for 10 min. Video recordings were analyzed offline using the "Animal Tracker" plug‐in developed for ImageJ (Gulyas *et al* [2016](#embj2018100087-bib-0504){ref-type="ref"}), including a virtual "spit arena" made up of central and peripheral areas, the latter defined as 8 and 18 cm from the wall for mice and rats, respectively. The time spent in each area, as well as the distance covered, was measured.

For *Scgn*‐Cre mice, a rectangular open‐field arena of 70 × 70 cm footprint with 30‐cm walls was used with assays lasting for 5 min. Subsequently, anxiety‐like behavioral phenotypes were determined in an elevated plus maze with uniform dimensions for its open and closed arms (32 cm in length and 5 cm in width) for 3 min. The apparatus was elevated 76.5 cm above the floor surface. A Smart Video Tracking System (Harvard Apparatus) was used for data processing offline. CNO was administered i.p. at a dose of 2 mg/kg of body weight to activate DREADD constructs *in vivo*, 15--20 min before each test. In both tests, animals were handled by an experimenter blinded to the case condition to ensure objectivity.

### *Ex vivo* electrophysiology and Ca^2+^ imaging {#embj2018100087-sec-0038}

We used 3‐ to 4‐week‐old mice (*n *=* *4--5/genotype) and a protective recovery method for acute brain slice preparation (Zhao *et al*, [2011](#embj2018100087-bib-0521){ref-type="ref"}). Briefly, mice were deeply anesthetized and perfused with 20 ml ice‐cold pre‐oxygenated (95% O~2~/5% CO~2~) solution containing (in mM) 93 N‐methyl‐D‐glutamine--HCl, 30 NaHCO~3~, 2.5 KCl, 1.2 NaH~2~PO~4~, 20 HEPES‐NaOH, 5 Na‐ascorbate, 3 Na‐pyruvate, 0.5 CaCl~2~, 8 MgSO~4~, and 25 glucose (pH 7.4). Brains were rapidly extracted and immersed in the same solution. Subsequently, 300‐μm‐thick coronal slices of the prefrontal cortex were cut on Leica VT1200S vibratome. Slices were then transferred to a recovery chamber filled with the same solution (32°C) for 12 min and later kept (minimum 60 min prior to the recordings) in a solution containing (in mM) 90 NaCl, 26 NaHCO~3~, 3 KCl, 1.2 NaH~2~PO~4~, 20 HEPES‐NaOH, 5 Na‐ascorbate, 3 Na‐pyruvate, 1.5 CaCl~2~, 2 MgSO~4~, 0.5 L‐glutathione, and 25 glucose (pH 7.4).

Patch‐clamp recordings as well as Ca^2+^ imaging of ependymal cells lining the 3^rd^ ventricle, NE neurons in the LC, and layer 5 pyramidal neurons in the mPFC (at \~+1.3 to +2.2 mm relative to bregma and prelimbic and infralimbic cortices) were performed in oxygenated (95% O~2~/5% CO~2~) artificial CSF containing (in mM) 124 NaCl, 2.5 KCl, 2 MgCl~2~, 1.5 CaCl~2~, 24 NaHCO~3~, 1.2 NaH~2~PO~4~, 5 HEPES, and 12.5 glucose. Patch pipettes with a resistance of 3--5 MΩ contained (in mM) 120 K‐gluconate, 6 KCl, 10 HEPES‐KOH, 5 EGTA, 4 ATP‐Mg, and 0.3 GTP (pH was adjusted to 7.3 with KOH). Perfusion speed was set to 2.5--3 ml/min. To record base current and spontaneous excitatory postsynaptic currents (sEPCs) in control and after application of 10 μM L‐norepinephrine (Sigma), pyramidal cells were clamped at −70 mV. CNO was used at a concentration of 10 μM to activate DREADDs *ex vivo*. Data were analyzed using Clampfit 10.0 (Molecular Devices), MiniAnalysis (Synaptosoft), and SigmaPlot (Systat).

Ca^2+^ imaging on retrogradely labeled NE neurons was done on an AxioExaminer.D1 microscope (Zeiss) equipped with a water‐immersion 20× Plan‐APOCHROMAT objective (Zeiss) and a CoolSNAP HQ^2^ camera (Photometrics). Illumination was provided by a VisiChrome monochromator (Visitron Systems) to excite GCaMP6f with data recorded and processed in the VisiView software (Romanov *et al*, [2017b](#embj2018100087-bib-0074){ref-type="ref"}).

*Ex vivo* optogenetics employed excitation switches between 470 nm and 535 nm on a pE‐100 CoolLED illumination system (CoolLED) at a uniform light intensity of 0.2 mW measured at the tissue surface.

### Statistical analysis {#embj2018100087-sec-0039}

Data were analyzed using the Statistical Package for the Social Sciences (version 21.0, SPSS Inc.). Integrated optical densities of immunoreactive targets in Western blotting or immunohistochemical experiments were evaluated using Student\'s *t*‐test (on independent samples). Drug effects in electrophysiology studies were defined by either one‐way ANOVA or paired Student\'s *t*‐test as appropriate. The behavior of knock‐out animals in the open‐field and elevated plus maze tests was evaluated by ANOVA using a general linear model with genotype, sex, and treatment being fixed factors followed by appropriate group comparisons. Behavioral data on pairs of treatment groups were routinely analyzed using the Mann--Whitney *U*‐test (one‐tailed where deemed appropriate) or Student\'s *t*‐test. Data are expressed as means ± s.e.m. A *P*‐value of \< 0.05 was considered statistically significant.

Data availability {#embj2018100087-sec-0040}
=================

Raw data files for single‐cell RNA sequencing have been deposited in NCBI Gene Expression Omnibus under accession number GEO: [GSE74672](GSE74672) (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74672>).
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